DSTYK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O00193 | S87 | Sugiyama | SMAP C11orf58 | FRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGFSEV |
| O00443 | S108 | Sugiyama | PIK3C2A | LDIDVEKLTQAELEKLLLDDsFETKKTPVLPVTPILSPSFS |
| O00625 | S225 | Sugiyama | PIR | PDDAQQKIEPHHTAVLGEGDsVQVENKDPKRSHFVLIAGEP |
| O14763 | S425 | Sugiyama | TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186 | ALETLGERLAKQKIEDHLLSsGKFMYLEGNADSAMS_____ |
| O14979 | S293 | Sugiyama | HNRNPDL HNRPDL JKTBP | RRGFCFITYTDEEPVKKLLEsRYHQIGSGKCEIKVAQPKEV |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15355 | S363 | Sugiyama | PPM1G PPM1C | VANAGDsRCVVsEAGKALDMsyDHKPEDEVELARIKNAGGK |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43399 | S103 | Sugiyama | TPD52L2 | LstLGELKQNLsRsWHDVQVssAyVKTSEKLGEWNEKVTQS |
| O43399 | S21 | Sugiyama | TPD52L2 | MDsAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGL |
| O43852 | S125 | Sugiyama | CALU | IyEDVERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDD |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60271 | S109 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | YEREKALRKHAEEKFIEFEDsQEQEKKDLQTRVESLESQTR |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60749 | S264 | Sugiyama | SNX2 TRG9 | QRTVKHPTLLQDPDLRQFLEssELPRAVNTQALsGAGILRM |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60831 | S19 | Sugiyama | PRAF2 JM4 | __MSEVRLPPLRALDDFVLGsARLAAPDPCDPQRWCHRVIN |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75391 | S63 | Sugiyama | SPAG7 | QQKVEFRKRMEKEVsDFIQDsGQIKKKFQPMNKIERSILHD |
| O75534 | S766 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | AAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDNsMGFG |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95721 | S210 | Sugiyama | SNAP29 | PKNPHLRAYHQKIDsNLDELsMGLGRLKDIALGMQTEIEEQ |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S237 | Sugiyama | LDHA PIG19 | DLGtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVA |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04150 | S125 | Sugiyama | NR3C1 GRL | PQQGQISLSSGETDLKLLEEsIANLNRstsVPENPKSSAST |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05783 | S323 | Sugiyama | KRT18 CYK18 PIG46 | VQsLEIDLDsMRNLKAsLENsLREVEARYALQMEQLNGILL |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T401 | Sugiyama | SLC3A2 MDU1 | NSSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQ |
| P08195 | T415 | Sugiyama | SLC3A2 MDU1 | NKDLLLtssyLsDsGstGEHtKSLVTQYLNATGNRWCSWSL |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P0DPH7 | T82 | Sugiyama | TUBA3C TUBA2 | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANN |
| P0DPH7 | Y83 | Sugiyama | TUBA3C TUBA2 | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S362 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | RIPKIQKLLQDFFNGKELNKsINPDEAVAyGAAVQAAILsG |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13073 | S74 | Sugiyama | COX4I1 COX4 | HLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAEMN |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P13987 | T85 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | WKFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGT |
| P14209 | S168 | Sugiyama | CD99 MIC2 MIC2X MIC2Y | YQKKKLCFKENAEQGEVDMEsHRNANAEPAVQRtLLEK___ |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P15311 | S413 | Sugiyama | EZR VIL2 | RMAALRAKEELERQAVDQIKsQEQLAAELAEytAKIALLEE |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T425 | Sugiyama | EZR VIL2 | RQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEEW |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15374 | S126 | Sugiyama | UCHL3 | NNKDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17480 | S364 | Sugiyama | UBTF UBF UBF1 | HKKCDQKKKDyEVELLRFLEsLPEEEQQRVLGEEKMLNINK |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P20810 | S295 | Sugiyama | CAST | QEKKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEV |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P20810 | S379 | Sugiyama | CAST | KPKPRsEsELIDELsEDFDRsECKEKPSKPTEKTEESKAAA |
| P22692 | S255 | Sugiyama | IGFBP4 IBP4 | VKLPGGLEPKGELDCHQLADsFRE_________________ |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25815 | S47 | Sugiyama | S100P S100E | tLTKGELKVLMEKELPGFLQsGKDKDAVDKLLKDLDANGDA |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T425 | Sugiyama | MSN | QAsRDQKKTQEQLALEMAELtARIsQLEMARQKKEsEAVEW |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S156 | Sugiyama | YWHAQ | DDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLGLALNFSV |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P29144 | S93 | Sugiyama | TPP2 | SGDVNTATEVEPKDGEIVGLsGRVLKIPASWTNPSGKYHIG |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29401 | S548 | Sugiyama | TKT | NIRVLDPFTIKPLDRKLILDsARAtKGRILTVEDHYYEGGI |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30622 | T731 | Sugiyama | CLIP1 CYLN1 RSN | EAIRSKLDKAEDQHLVEMEDtLNKLQEAEIKVKELEVLQAK |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1376 | Sugiyama | MYH9 | EKQIATLHAQVADMKKKMEDsVGCLEtAEEVKRKLQKDLEG |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35580 | T1320 | Sugiyama | MYH10 | EKKGIKFAKDAAsLEsQLQDtQELLQEETRQKLNLSSRIRQ |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S240 | Sugiyama | MATR3 KIAA0723 | EDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPL |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46937 | S388 | Sugiyama | YAP1 YAP65 | PGMsQELRTMttNssDPFLNsGtyHsRDEstDsGLsMssys |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P49736 | S170 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KRRQVERAtEDGEEDEEMIEsIENLEDLKGHSVREWVsMAG |
| P51858 | S239 | Sugiyama | HDGF HMG1L2 | DEEEEAtKEDAEAPGIRDHEsL___________________ |
| P51946 | S322 | Sugiyama | CCNH | YVsKKSKHEEEEWtDDDLVEsL___________________ |
| P53999 | S10 | Sugiyama | SUB1 PC4 RPO2TC1 | ___________MPKSKELVsssssGsDsDsEVDKKLKRKKQ |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S97 | Sugiyama | TPI1 TPI | GEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELIGQKVAHA |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62316 | S30 | Sugiyama | SNRPD2 SNRPD1 | EMtPEELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNK |
| P62316 | S35 | Sugiyama | SNRPD2 SNRPD1 | ELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGR |
| P62316 | T33 | Sugiyama | SNRPD2 SNRPD1 | PEELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLL |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00341 | S216 | Sugiyama | HDLBP HBP VGL | IKITGTKEGIEKARHEVLLIsAEQDKRAVERLEVEKAFHPF |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01814 | S1242 | Sugiyama | ATP2B2 PMCA2 | DtsKSATSSsPGsPIHSLEtsL___________________ |
| Q05682 | S129 | Sugiyama | CALD1 CAD CDM | KRLQEALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEK |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q09666 | S298 | Sugiyama | AHNAK PM227 | VDIsssLGGRAVEVQGPsLEsGDHGKIKFPTMKVPKFGVST |
| Q12906 | S317 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | KEAtDAIGHLDRQQREDItQsAQHALRLAAFGQLHKVLGMD |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13435 | S307 | Sugiyama | SF3B2 SAP145 | MNsQQEEEEMETDARssLGQsAsEtEEDtVsVsKKEKNRKR |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13561 | T114 | Sugiyama | DCTN2 DCTN50 | GVKETPQQKYQRLLHEVQELtTEVEKIKTTVKEsATEEKLt |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14151 | S207 | Sugiyama | SAFB2 KIAA0138 | FKNtLEtssLNFKVtPDIEEsLLEPENEKILDILGEtCKsE |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14257 | T297 | Sugiyama | RCN2 ERC55 | LNGDKKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14980 | S1149 | Sugiyama | NUMA1 NMP22 NUMA | VSKLEQQCQKQQEQADsLERsLEAERASRAERDsALEtLQG |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15599 | S298 | Sugiyama | NHERF2 SLC9A3R2 | PGsDKDtEDGSAWKQDPFQEsGLHLsPtAAEAKEKARAMRV |
| Q16513 | S591 | Sugiyama | PKN2 PRK2 PRKCL2 | EPEPPPAPPRAssLGEIDEssELRVLDIPGQDsEtVFDIQN |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q27J81 | S1192 | Sugiyama | INF2 C14orf151 C14orf173 | EDEDEEDtAPEsALDtsLDKsFsEDAVtDssGsGtLPRARG |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q53EL6 | S48 | Sugiyama | PDCD4 H731 | EENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNss |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5JSH3 | S71 | Sugiyama | WDR44 RPH11 | PVQELKQDVSKKIIEsIIEEsQKVLQLEDDsLDSKGKELsD |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5VT52 | S1177 | Sugiyama | RPRD2 KIAA0460 HSPC099 | GGLTGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPs |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6PEY2 | T82 | Sugiyama | TUBA3E | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASN |
| Q6PEY2 | Y83 | Sugiyama | TUBA3E | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASNY |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6XUX3 | S291 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | YFSFPVFFFKVPKLGSEIIDssTRRMESERSPLYRQLIDLG |
| Q6XUX3 | S292 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | FSFPVFFFKVPKLGSEIIDssTRRMESERSPLYRQLIDLGY |
| Q6XUX3 | S315 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | RMESERSPLYRQLIDLGYLSsSHWNCGAPGQDTKAQSMLVE |
| Q6XUX3 | S337 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | HWNCGAPGQDTKAQSMLVEQsEKLRHLSTFSHQVLQTRLVD |
| Q6XUX3 | S404 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | LQITPKRLEYTRKKENELYEsLMNIANRKQEEMKDMIVEtL |
| Q6XUX3 | S483 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | QIQELIISRLNQAVANKLISsVDyLRESFVGtLERCLQSLE |
| Q6XUX3 | S575 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | VSPPAITLEWKRKVAQEAIEsLsAsKLAKSICSQFRTRLNS |
| Q6XUX3 | S577 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | PPAITLEWKRKVAQEAIEsLsAsKLAKSICSQFRTRLNSsH |
| Q6XUX3 | S579 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | AITLEWKRKVAQEAIEsLsAsKLAKSICSQFRTRLNSsHEA |
| Q6XUX3 | S58 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | LGRLRQNLRETQKFFRDIKCsHNHtCLssLtGGGGAERGPA |
| Q6XUX3 | S596 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | LsAsKLAKSICSQFRTRLNSsHEAFAAsLRQLEAGHSGRLE |
| Q6XUX3 | S603 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | KSICSQFRTRLNSsHEAFAAsLRQLEAGHSGRLEKtEDLWL |
| Q6XUX3 | S65 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | LRETQKFFRDIKCsHNHtCLssLtGGGGAERGPAGDVAETG |
| Q6XUX3 | S66 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | RETQKFFRDIKCsHNHtCLssLtGGGGAERGPAGDVAETGL |
| Q6XUX3 | S770 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | TLETRLQIALDVVEGIRFLHsQGLVHRDIKLKNVLLDKQNR |
| Q6XUX3 | T423 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | EsLMNIANRKQEEMKDMIVEtLNtMKEELLDDAtNMEFKDV |
| Q6XUX3 | T426 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | MNIANRKQEEMKDMIVEtLNtMKEELLDDAtNMEFKDVIVP |
| Q6XUX3 | T436 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | MKDMIVEtLNtMKEELLDDAtNMEFKDVIVPENGEPVGTRE |
| Q6XUX3 | T494 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | QAVANKLISsVDyLRESFVGtLERCLQSLEKSQDVSVHITS |
| Q6XUX3 | T618 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | EAFAAsLRQLEAGHSGRLEKtEDLWLRVRKDHAPRLARLSL |
| Q6XUX3 | T62 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | RQNLRETQKFFRDIKCsHNHtCLssLtGGGGAERGPAGDVA |
| Q6XUX3 | T68 | Sugiyama | DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P | TQKFFRDIKCsHNHtCLssLtGGGGAERGPAGDVAETGLQA |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86V48 | S1042 | Sugiyama | LUZP1 | ASMEEEGEDCTLSVYRQLHNsLDPSELPGKQGLPESGRVRA |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q8N6H7 | S368 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | VGTFASGPPKYKDNPFsLGEsFGsRWDTDAAWGMDRVEEKE |
| Q8NBJ7 | S264 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | AAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPDsAsD |
| Q8NBK3 | S234 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | AVAYCTWAGKRLPTEAEWEYsCRGGLHNRLFPWGNKLQPKG |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8NEF9 | S264 | Sugiyama | SRFBP1 | SGNsDGGEEFCEEEKEYFDDstEERFYKQSsMSEDsDsGDD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92769 | S424 | Sugiyama | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92900 | S1110 | Sugiyama | UPF1 KIAA0221 RENT1 | QDSYLGDEFKsQIDVALsQDstyQGERAyQHGGVtGLsQy_ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96CT7 | S155 | Sugiyama | CCDC124 | RVLEEGsVEARTIEDAIAVLsVAEEAADRHPERRMRAAFTA |
| Q96CT7 | T103 | Sugiyama | CCDC124 | GGKAPRVATSSKVTRAQIEDtLRRDHQLREAPDTAEKAKsH |
| Q96QK1 | S760 | Sugiyama | VPS35 MEM3 TCCCTA00141 | IQVLNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRLR |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99613 | S639 | Sugiyama | EIF3C EIF3S8 | CAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQERN |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BR76 | S391 | Sugiyama | CORO1B | EAALEAEEWVSGRDADPILIsLREAYVPSKQRDLKISRRNV |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BX40 | S349 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | SSRRTTWAEERKLNtEtFGVsGRFLRGRSSRGGFRGGRGNG |
| Q9BXS6 | S363 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TtEAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQS |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9H1E3 | S19 | Sugiyama | NUCKS1 NUCKS JC7 | __MSRPVRNRKVVDysQFQEsDDADEDyGRDsGPPtKKIRS |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9NTJ3 | S466 | Sugiyama | SMC4 CAPC SMC4L1 | NNALEKEKEKEEKKLKEVMDsLKQETQGLQKEKESREKELM |
| Q9NW68 | S17 | Sugiyama | BSDC1 UNQ2494/PRO5781 | ____MAEGEDVGWWRSWLQQsYQAVKEKSSEALEFMKRDLT |
| Q9NYF8 | S427 | Sugiyama | BCLAF1 BTF KIAA0164 | DyRQFRKsVLADQGKsFATAsHRNtEEEGLKyKSKVSLKGN |
| Q9UBC2 | S518 | Sugiyama | EPS15L1 EPS15R | LNRAKSELNRLQQEETQLEQsIQAGRVQLETIIKSLKSTQD |
| Q9UHI6 | S678 | Sugiyama | DDX20 DP103 GEMIN3 | SySSRTSSQSKGNKsyLEGssDNQLKDsEstPVDDRIsLEQ |
| Q9UNF0 | S273 | Sugiyama | PACSIN2 | KHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFRANHGPG |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UNZ2 | S74 | Sugiyama | NSFL1C UBXN2C | SQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQRF |
| Q9UQE7 | S886 | Sugiyama | SMC3 BAM BMH CSPG6 SMC3L1 | LEAINKRVKDTMARSEDLDNsIDKTEAGIKELQKSMERWKN |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2X3 | S509 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KRGKKKHIKEEPLsEEEPCtstAIAsPEKKKKKKKKRENED |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5K6 | S463 | Sugiyama | CD2AP | SKLKLDsEQLPLRPKsVDFDsLtVRtsKEtDVVNFDDIASS |
| Q9Y5K6 | T465 | Sugiyama | CD2AP | LKLDsEQLPLRPKsVDFDsLtVRtsKEtDVVNFDDIASSEN |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 6.661338e-16 | 15.176 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.611245e-13 | 12.583 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.749267e-12 | 11.757 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.903000e-11 | 10.721 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.995860e-11 | 10.000 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.322785e-10 | 9.080 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.266788e-09 | 8.645 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.266788e-09 | 8.645 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.402148e-09 | 8.468 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.140494e-09 | 8.383 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.775385e-08 | 7.751 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.449937e-08 | 7.611 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.289552e-08 | 7.483 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.198625e-08 | 7.495 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.056667e-08 | 7.515 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.703002e-08 | 7.431 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.724983e-08 | 7.429 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.075061e-08 | 7.042 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.674704e-07 | 6.776 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.843264e-07 | 6.734 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.014464e-07 | 6.696 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.121772e-07 | 6.385 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.825156e-07 | 6.316 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.789016e-07 | 6.109 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.604904e-07 | 6.119 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.304370e-07 | 6.136 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.283723e-07 | 6.082 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.227382e-06 | 5.911 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.227382e-06 | 5.911 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.835325e-06 | 5.736 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.053197e-06 | 5.688 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.983663e-06 | 5.703 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.036725e-06 | 5.691 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.305665e-06 | 5.637 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.596090e-06 | 5.338 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.521175e-06 | 5.258 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.073608e-06 | 5.217 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.240632e-06 | 5.205 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.777025e-06 | 5.169 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.740356e-06 | 5.171 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.707780e-06 | 5.173 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.336517e-06 | 5.135 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.757859e-06 | 5.058 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.463532e-05 | 4.835 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.684458e-05 | 4.774 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.684458e-05 | 4.774 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.684458e-05 | 4.774 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.684458e-05 | 4.774 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.085876e-05 | 4.681 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.259233e-05 | 4.487 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.035638e-05 | 4.394 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.102386e-05 | 4.387 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.176804e-05 | 4.379 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.205761e-05 | 4.376 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.753883e-05 | 4.323 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.812762e-05 | 4.318 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.566196e-05 | 4.183 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.064721e-05 | 4.151 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.656621e-05 | 4.116 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.869383e-05 | 4.052 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.271223e-05 | 4.033 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.075388e-04 | 3.968 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.057548e-04 | 3.976 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.977989e-05 | 4.001 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.051153e-04 | 3.978 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.057170e-04 | 3.976 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.099303e-04 | 3.959 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.300250e-04 | 3.886 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.339338e-04 | 3.873 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.499160e-04 | 3.824 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.502564e-04 | 3.823 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.730334e-04 | 3.762 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.771625e-04 | 3.752 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.229087e-04 | 3.652 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.370293e-04 | 3.625 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.639697e-04 | 3.578 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.639697e-04 | 3.578 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.673551e-04 | 3.573 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.903352e-04 | 3.537 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.940068e-04 | 3.532 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.957338e-04 | 3.529 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.980301e-04 | 3.526 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.138649e-04 | 3.503 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.138649e-04 | 3.503 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.281100e-04 | 3.484 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.747161e-04 | 3.426 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.853530e-04 | 3.414 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.961636e-04 | 3.402 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.977039e-04 | 3.400 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.366939e-04 | 3.360 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.637585e-04 | 3.334 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.780076e-04 | 3.321 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.503239e-04 | 3.259 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.861354e-04 | 3.232 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.861354e-04 | 3.232 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.921943e-04 | 3.228 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.756522e-04 | 3.170 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.801496e-04 | 3.167 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.623381e-04 | 3.118 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.689402e-04 | 3.114 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.689402e-04 | 3.114 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.851633e-04 | 3.105 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.851633e-04 | 3.105 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.256015e-04 | 3.083 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.343770e-04 | 3.079 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.210618e-04 | 3.036 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.936881e-04 | 3.049 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.757830e-04 | 3.011 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.015809e-03 | 2.993 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.120042e-03 | 2.951 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.214511e-03 | 2.916 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.219592e-03 | 2.914 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.313544e-03 | 2.882 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.271770e-03 | 2.896 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.500578e-03 | 2.824 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.566245e-03 | 2.805 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.652265e-03 | 2.782 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.844802e-03 | 2.734 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.844802e-03 | 2.734 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.880364e-03 | 2.726 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.075988e-03 | 2.683 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.336859e-03 | 2.631 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.336859e-03 | 2.631 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.288638e-03 | 2.640 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.483976e-03 | 2.605 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.508171e-03 | 2.601 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.508171e-03 | 2.601 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.583552e-03 | 2.588 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.885002e-03 | 2.540 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.679406e-03 | 2.572 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.895442e-03 | 2.538 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.895442e-03 | 2.538 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.944179e-03 | 2.531 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.124151e-03 | 2.505 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.199518e-03 | 2.495 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.259759e-03 | 2.487 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.333295e-03 | 2.477 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.638988e-03 | 2.439 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.275630e-03 | 2.369 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.256657e-03 | 2.371 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.316270e-03 | 2.365 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.256657e-03 | 2.371 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.525152e-03 | 2.344 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.541556e-03 | 2.343 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.673814e-03 | 2.330 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.673814e-03 | 2.330 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.938983e-03 | 2.306 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.129360e-03 | 2.290 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.315039e-03 | 2.274 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.315039e-03 | 2.274 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.315039e-03 | 2.274 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.113553e-03 | 2.214 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.113553e-03 | 2.214 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.800945e-03 | 2.237 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.152888e-03 | 2.211 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.282536e-03 | 2.202 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.361225e-03 | 2.196 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.500609e-03 | 2.187 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.539569e-03 | 2.184 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.568882e-03 | 2.183 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.065041e-03 | 2.151 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.188558e-03 | 2.143 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.331556e-03 | 2.135 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.886919e-03 | 2.103 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.867185e-03 | 2.104 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.122603e-03 | 2.090 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.867185e-03 | 2.104 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.636432e-03 | 2.064 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.886919e-03 | 2.103 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.849494e-03 | 2.053 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.272058e-03 | 2.033 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.272058e-03 | 2.033 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.272058e-03 | 2.033 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.358001e-03 | 2.029 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.358001e-03 | 2.029 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.358001e-03 | 2.029 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.358001e-03 | 2.029 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.570779e-03 | 2.019 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.902878e-03 | 2.004 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 9.973831e-03 | 2.001 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.101694e-02 | 1.958 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.102787e-02 | 1.958 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.210592e-02 | 1.917 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.247269e-02 | 1.904 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.247269e-02 | 1.904 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.247269e-02 | 1.904 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.247269e-02 | 1.904 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.247269e-02 | 1.904 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.173283e-02 | 1.931 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.300244e-02 | 1.886 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.305399e-02 | 1.884 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.323560e-02 | 1.878 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.323560e-02 | 1.878 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.324681e-02 | 1.878 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.400026e-02 | 1.854 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.507075e-02 | 1.822 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.507075e-02 | 1.822 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.524799e-02 | 1.817 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.540242e-02 | 1.812 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.540242e-02 | 1.812 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.713200e-02 | 1.766 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.644706e-02 | 1.784 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.875390e-02 | 1.727 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.690888e-02 | 1.772 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.856969e-02 | 1.731 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.644706e-02 | 1.784 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.781591e-02 | 1.749 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.644706e-02 | 1.784 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.853911e-02 | 1.732 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.822285e-02 | 1.739 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.644706e-02 | 1.784 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.777295e-02 | 1.750 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.875390e-02 | 1.727 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.658029e-02 | 1.780 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.713200e-02 | 1.766 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.897044e-02 | 1.722 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.911009e-02 | 1.719 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.914110e-02 | 1.718 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.926081e-02 | 1.715 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.059640e-02 | 1.686 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.110089e-02 | 1.676 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.118804e-02 | 1.674 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.118804e-02 | 1.674 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.142711e-02 | 1.669 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.501117e-02 | 1.602 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.501117e-02 | 1.602 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.501117e-02 | 1.602 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.501117e-02 | 1.602 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.501117e-02 | 1.602 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.501117e-02 | 1.602 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.366922e-02 | 1.626 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.500135e-02 | 1.602 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.228033e-02 | 1.652 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.228033e-02 | 1.652 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.499596e-02 | 1.602 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.499596e-02 | 1.602 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.279204e-02 | 1.642 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.500135e-02 | 1.602 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.228033e-02 | 1.652 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.348875e-02 | 1.629 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.344879e-02 | 1.630 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.277077e-02 | 1.643 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.409877e-02 | 1.618 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.148703e-02 | 1.668 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.393572e-02 | 1.621 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.155018e-02 | 1.667 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.277077e-02 | 1.643 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.277077e-02 | 1.643 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.228033e-02 | 1.652 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.393572e-02 | 1.621 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.533480e-02 | 1.596 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.537715e-02 | 1.596 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.642575e-02 | 1.578 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.642575e-02 | 1.578 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.721262e-02 | 1.565 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.752303e-02 | 1.560 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.843368e-02 | 1.546 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.926545e-02 | 1.534 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.931085e-02 | 1.533 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.999720e-02 | 1.523 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.999720e-02 | 1.523 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.999720e-02 | 1.523 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.999720e-02 | 1.523 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.999720e-02 | 1.523 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.999720e-02 | 1.523 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.090201e-02 | 1.510 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.104060e-02 | 1.508 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.104060e-02 | 1.508 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.104060e-02 | 1.508 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.104060e-02 | 1.508 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.104060e-02 | 1.508 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.112227e-02 | 1.507 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.182728e-02 | 1.497 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.747130e-02 | 1.426 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.747130e-02 | 1.426 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.747130e-02 | 1.426 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.747130e-02 | 1.426 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.473277e-02 | 1.459 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.473277e-02 | 1.459 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.775561e-02 | 1.423 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.402035e-02 | 1.468 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.537885e-02 | 1.451 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.523712e-02 | 1.453 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.760030e-02 | 1.425 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.747130e-02 | 1.426 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.473277e-02 | 1.459 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.760030e-02 | 1.425 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.402035e-02 | 1.468 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.523712e-02 | 1.453 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.849619e-02 | 1.415 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.402035e-02 | 1.468 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.987349e-02 | 1.399 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.069286e-02 | 1.390 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.151765e-02 | 1.382 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.195648e-02 | 1.377 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.395717e-02 | 1.357 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.397969e-02 | 1.357 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.397969e-02 | 1.357 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.479498e-02 | 1.349 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.479498e-02 | 1.349 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.524288e-02 | 1.344 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.555734e-02 | 1.341 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.608383e-02 | 1.336 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.637253e-02 | 1.334 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.637253e-02 | 1.334 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.637253e-02 | 1.334 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.637253e-02 | 1.334 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.637253e-02 | 1.334 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.637253e-02 | 1.334 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.686531e-02 | 1.329 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.712777e-02 | 1.327 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.718984e-02 | 1.326 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.718984e-02 | 1.326 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.718984e-02 | 1.326 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.718984e-02 | 1.326 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.718984e-02 | 1.326 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.775926e-02 | 1.321 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.893832e-02 | 1.310 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.893832e-02 | 1.310 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.999436e-02 | 1.301 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.025930e-02 | 1.299 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.084344e-02 | 1.294 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.084344e-02 | 1.294 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.084344e-02 | 1.294 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.108081e-02 | 1.292 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.140148e-02 | 1.289 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.140148e-02 | 1.289 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.163807e-02 | 1.287 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 5.202009e-02 | 1.284 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.202009e-02 | 1.284 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.454761e-02 | 1.263 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.992033e-02 | 1.222 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.992033e-02 | 1.222 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.810005e-02 | 1.236 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.387284e-02 | 1.269 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.654841e-02 | 1.177 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.654841e-02 | 1.177 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.574281e-02 | 1.182 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.574281e-02 | 1.182 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.739937e-02 | 1.241 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.420839e-02 | 1.192 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.420839e-02 | 1.192 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.420839e-02 | 1.192 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.515351e-02 | 1.258 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.616487e-02 | 1.179 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.578256e-02 | 1.182 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.574281e-02 | 1.182 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.739937e-02 | 1.241 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.420839e-02 | 1.192 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.992033e-02 | 1.222 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.739937e-02 | 1.241 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.444652e-02 | 1.264 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.444652e-02 | 1.264 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.616487e-02 | 1.179 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.381333e-02 | 1.195 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.584413e-02 | 1.181 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.689934e-02 | 1.175 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.920944e-02 | 1.160 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.920944e-02 | 1.160 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.262251e-02 | 1.139 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.377106e-02 | 1.132 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.377106e-02 | 1.132 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.468930e-02 | 1.127 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.468930e-02 | 1.127 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.468930e-02 | 1.127 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.476009e-02 | 1.126 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.476009e-02 | 1.126 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.476009e-02 | 1.126 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.476009e-02 | 1.126 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.533452e-02 | 1.123 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.533452e-02 | 1.123 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.533452e-02 | 1.123 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.540773e-02 | 1.123 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.540773e-02 | 1.123 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.554824e-02 | 1.122 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.598889e-02 | 1.119 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.598889e-02 | 1.119 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.958717e-02 | 1.099 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.155622e-02 | 1.089 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.187049e-02 | 1.087 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.386655e-02 | 1.076 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.386655e-02 | 1.076 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.386655e-02 | 1.076 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.494278e-02 | 1.071 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.494278e-02 | 1.071 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.494278e-02 | 1.071 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.512272e-02 | 1.070 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.556014e-02 | 1.068 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.556014e-02 | 1.068 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.556014e-02 | 1.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.556014e-02 | 1.068 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.586908e-02 | 1.066 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.621088e-02 | 1.064 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.662097e-02 | 1.062 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.662097e-02 | 1.062 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.670623e-02 | 1.062 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.670623e-02 | 1.062 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.848599e-02 | 1.053 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.864622e-02 | 1.052 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.931578e-02 | 1.049 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.931578e-02 | 1.049 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.045176e-02 | 1.044 | 0 | 0 |
| Defective F9 secretion | R-HSA-9673218 | 1.141090e-01 | 0.943 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.141090e-01 | 0.943 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.141090e-01 | 0.943 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 9.761080e-02 | 1.011 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.229793e-01 | 0.910 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.229793e-01 | 0.910 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.229793e-01 | 0.910 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.229793e-01 | 0.910 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.114246e-01 | 0.953 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.146895e-01 | 0.940 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.135192e-01 | 0.945 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.805351e-02 | 1.009 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.060264e-01 | 0.975 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.060264e-01 | 0.975 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.175571e-01 | 0.930 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.116586e-01 | 0.952 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.156157e-01 | 0.937 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.156157e-01 | 0.937 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.457104e-02 | 1.024 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.135263e-01 | 0.945 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.057903e-01 | 0.976 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.060264e-01 | 0.975 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.175571e-01 | 0.930 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.156157e-01 | 0.937 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.963475e-02 | 1.002 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.225538e-01 | 0.912 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.136254e-01 | 0.945 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.146895e-01 | 0.940 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.013254e-01 | 0.994 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.183419e-01 | 0.927 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.224007e-01 | 0.912 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.072165e-01 | 0.970 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.102726e-01 | 0.958 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.135192e-01 | 0.945 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.013254e-01 | 0.994 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.175571e-01 | 0.930 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.674843e-02 | 1.014 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.217866e-01 | 0.914 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.457104e-02 | 1.024 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 9.761080e-02 | 1.011 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.963475e-02 | 1.002 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.060264e-01 | 0.975 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.135192e-01 | 0.945 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.245870e-02 | 1.034 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.232583e-01 | 0.909 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.232583e-01 | 0.909 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.232583e-01 | 0.909 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.237906e-01 | 0.907 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.237906e-01 | 0.907 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.237906e-01 | 0.907 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.237906e-01 | 0.907 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.250321e-01 | 0.903 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.259332e-01 | 0.900 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.276703e-01 | 0.894 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.281359e-01 | 0.892 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.283242e-01 | 0.892 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.300321e-01 | 0.886 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.318645e-01 | 0.880 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.318645e-01 | 0.880 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.318645e-01 | 0.880 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.318645e-01 | 0.880 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.318645e-01 | 0.880 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.318645e-01 | 0.880 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.318645e-01 | 0.880 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.318645e-01 | 0.880 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.384613e-01 | 0.859 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.418102e-01 | 0.848 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.425199e-01 | 0.846 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.434341e-01 | 0.843 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.440069e-01 | 0.842 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.440948e-01 | 0.841 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.443929e-01 | 0.840 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.449687e-01 | 0.839 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.486854e-01 | 0.828 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.490056e-01 | 0.827 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.492584e-01 | 0.826 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.501124e-01 | 0.824 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.501124e-01 | 0.824 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.501124e-01 | 0.824 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.504374e-01 | 0.823 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.514218e-01 | 0.820 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.537105e-01 | 0.813 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.537105e-01 | 0.813 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.551827e-01 | 0.809 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.559098e-01 | 0.807 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.559098e-01 | 0.807 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.583068e-01 | 0.801 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.584781e-01 | 0.800 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.597330e-01 | 0.797 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.597330e-01 | 0.797 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.600608e-01 | 0.796 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.600608e-01 | 0.796 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.605170e-01 | 0.794 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.605170e-01 | 0.794 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.614451e-01 | 0.792 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.652055e-01 | 0.782 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.652055e-01 | 0.782 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.652055e-01 | 0.782 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.652055e-01 | 0.782 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.652055e-01 | 0.782 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.652055e-01 | 0.782 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.652055e-01 | 0.782 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.655113e-01 | 0.781 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.665334e-01 | 0.778 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.665334e-01 | 0.778 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.152030e-01 | 0.667 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.152030e-01 | 0.667 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.152030e-01 | 0.667 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.152030e-01 | 0.667 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.152030e-01 | 0.667 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.152030e-01 | 0.667 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.152030e-01 | 0.667 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.152030e-01 | 0.667 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.152030e-01 | 0.667 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.085812e-01 | 0.681 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.085812e-01 | 0.681 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.085812e-01 | 0.681 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.085812e-01 | 0.681 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.085812e-01 | 0.681 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.085812e-01 | 0.681 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.085812e-01 | 0.681 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.085812e-01 | 0.681 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.796206e-01 | 0.746 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.529316e-01 | 0.597 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.529316e-01 | 0.597 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.529316e-01 | 0.597 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.101698e-01 | 0.677 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.101698e-01 | 0.677 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.417406e-01 | 0.617 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.417406e-01 | 0.617 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.417406e-01 | 0.617 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.009745e-01 | 0.697 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.009745e-01 | 0.697 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.693540e-01 | 0.771 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.894945e-01 | 0.722 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.260544e-01 | 0.646 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.518718e-01 | 0.599 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.518718e-01 | 0.599 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.957904e-01 | 0.708 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.320759e-01 | 0.634 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.320759e-01 | 0.634 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.719026e-01 | 0.765 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.328826e-01 | 0.633 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.833484e-01 | 0.737 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.797295e-01 | 0.745 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.906256e-01 | 0.720 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.209868e-01 | 0.656 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.171925e-01 | 0.663 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.518718e-01 | 0.599 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.768029e-01 | 0.753 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.148782e-01 | 0.668 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.507086e-01 | 0.601 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.430494e-01 | 0.614 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.777985e-01 | 0.750 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.417406e-01 | 0.617 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.009745e-01 | 0.697 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.101698e-01 | 0.677 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.693540e-01 | 0.771 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.148782e-01 | 0.668 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.073414e-01 | 0.683 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.073414e-01 | 0.683 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.073414e-01 | 0.683 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 2.101698e-01 | 0.677 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.952306e-01 | 0.709 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.896919e-01 | 0.722 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.133060e-01 | 0.671 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.780154e-01 | 0.750 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.260544e-01 | 0.646 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.529316e-01 | 0.597 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.894945e-01 | 0.722 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.518718e-01 | 0.599 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.009745e-01 | 0.697 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.148782e-01 | 0.668 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.148782e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.714737e-01 | 0.766 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.988645e-01 | 0.701 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.152030e-01 | 0.667 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.085812e-01 | 0.681 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.009745e-01 | 0.697 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.009745e-01 | 0.697 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.260544e-01 | 0.646 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.104358e-01 | 0.677 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.320759e-01 | 0.634 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.133060e-01 | 0.671 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.777985e-01 | 0.750 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.471340e-01 | 0.607 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.417406e-01 | 0.617 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.699583e-01 | 0.770 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.691454e-01 | 0.772 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.796206e-01 | 0.746 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.336418e-01 | 0.631 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.423304e-01 | 0.616 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.822800e-01 | 0.739 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.035515e-01 | 0.691 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.101698e-01 | 0.677 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.085812e-01 | 0.681 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.320759e-01 | 0.634 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.986185e-01 | 0.702 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.358492e-01 | 0.627 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.976679e-01 | 0.704 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.132081e-01 | 0.671 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.341828e-01 | 0.630 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.518718e-01 | 0.599 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.308060e-01 | 0.637 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.144275e-01 | 0.669 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.849527e-01 | 0.733 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.777985e-01 | 0.750 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.993890e-01 | 0.700 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.493007e-01 | 0.603 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.530020e-01 | 0.597 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.530726e-01 | 0.597 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.533627e-01 | 0.596 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.533627e-01 | 0.596 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.543109e-01 | 0.595 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.552938e-01 | 0.593 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.552938e-01 | 0.593 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.557521e-01 | 0.592 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.563665e-01 | 0.591 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.584859e-01 | 0.588 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.593755e-01 | 0.586 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.603012e-01 | 0.585 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.047658e-01 | 0.516 | 0 | 0 |
| Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-5619099 | 3.047658e-01 | 0.516 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.047658e-01 | 0.516 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.047658e-01 | 0.516 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.047658e-01 | 0.516 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.047658e-01 | 0.516 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.841122e-01 | 0.416 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.841122e-01 | 0.416 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.841122e-01 | 0.416 | 0 | 0 |
| Defective factor IX causes thrombophilia | R-HSA-9672383 | 3.841122e-01 | 0.416 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.841122e-01 | 0.416 | 0 | 0 |
| Defective cofactor function of FVIIIa variant | R-HSA-9672396 | 3.841122e-01 | 0.416 | 0 | 0 |
| Defective F9 variant does not activate FX | R-HSA-9673202 | 3.841122e-01 | 0.416 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.841122e-01 | 0.416 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.974699e-01 | 0.527 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.974699e-01 | 0.527 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.974699e-01 | 0.527 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.974699e-01 | 0.527 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.974699e-01 | 0.527 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.740100e-01 | 0.562 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.740100e-01 | 0.562 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.740100e-01 | 0.562 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.415761e-01 | 0.467 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.415761e-01 | 0.467 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.415761e-01 | 0.467 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.544069e-01 | 0.343 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.544069e-01 | 0.343 | 0 | 0 |
| Defective gamma-carboxylation of F9 | R-HSA-9673240 | 4.544069e-01 | 0.343 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.544069e-01 | 0.343 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 4.544069e-01 | 0.343 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.544069e-01 | 0.343 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.544069e-01 | 0.343 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.544069e-01 | 0.343 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.544069e-01 | 0.343 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.544069e-01 | 0.343 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.066800e-01 | 0.513 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.066800e-01 | 0.513 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.847690e-01 | 0.415 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.847690e-01 | 0.415 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.847690e-01 | 0.415 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.847690e-01 | 0.415 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.847690e-01 | 0.415 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.847690e-01 | 0.415 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.847690e-01 | 0.415 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.394805e-01 | 0.469 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.050540e-01 | 0.516 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.770365e-01 | 0.557 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.770365e-01 | 0.557 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.770365e-01 | 0.557 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.321017e-01 | 0.479 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.721703e-01 | 0.429 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.266828e-01 | 0.370 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.266828e-01 | 0.370 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.266828e-01 | 0.370 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.266828e-01 | 0.370 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.266828e-01 | 0.370 | 0 | 0 |
| Alternative complement activation | R-HSA-173736 | 5.166821e-01 | 0.287 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.166821e-01 | 0.287 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.166821e-01 | 0.287 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.166821e-01 | 0.287 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.166821e-01 | 0.287 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.166821e-01 | 0.287 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.592563e-01 | 0.445 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.592563e-01 | 0.445 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.148476e-01 | 0.502 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.045370e-01 | 0.393 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.863820e-01 | 0.413 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.670470e-01 | 0.331 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 4.670470e-01 | 0.331 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.670470e-01 | 0.331 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.670470e-01 | 0.331 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.826729e-01 | 0.549 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.570583e-01 | 0.447 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.363964e-01 | 0.360 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.363964e-01 | 0.360 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.363964e-01 | 0.360 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.896654e-01 | 0.538 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.333552e-01 | 0.477 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.131955e-01 | 0.504 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.395199e-01 | 0.469 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.665160e-01 | 0.574 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.180925e-01 | 0.379 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.400579e-01 | 0.356 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.675916e-01 | 0.330 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.056694e-01 | 0.296 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.710412e-01 | 0.567 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.208441e-01 | 0.376 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.840774e-01 | 0.547 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.784676e-01 | 0.422 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.414419e-01 | 0.355 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.414419e-01 | 0.355 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.922655e-01 | 0.308 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.593924e-01 | 0.338 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.803024e-01 | 0.318 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.803024e-01 | 0.318 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.042465e-01 | 0.297 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.581489e-01 | 0.446 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.967138e-01 | 0.402 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.244608e-01 | 0.280 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.876472e-01 | 0.312 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.872471e-01 | 0.542 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.967053e-01 | 0.402 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.180925e-01 | 0.379 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.415327e-01 | 0.355 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.670470e-01 | 0.331 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.050540e-01 | 0.516 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.629609e-01 | 0.334 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.415327e-01 | 0.355 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.244608e-01 | 0.280 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.199102e-01 | 0.377 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.592563e-01 | 0.445 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.471325e-01 | 0.460 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.287330e-01 | 0.483 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.069487e-01 | 0.390 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.358776e-01 | 0.474 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.415761e-01 | 0.467 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.415761e-01 | 0.467 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.782592e-01 | 0.556 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.394805e-01 | 0.469 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.670470e-01 | 0.331 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.524747e-01 | 0.344 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.677437e-01 | 0.572 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.847690e-01 | 0.415 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.770365e-01 | 0.557 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.584181e-01 | 0.446 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.064702e-01 | 0.514 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.471325e-01 | 0.460 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.156388e-01 | 0.501 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.837319e-01 | 0.315 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.233006e-01 | 0.490 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.208263e-01 | 0.283 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.761115e-01 | 0.425 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.142326e-01 | 0.289 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.782592e-01 | 0.556 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.863820e-01 | 0.413 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.761115e-01 | 0.425 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.094259e-01 | 0.388 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.670470e-01 | 0.331 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.238912e-01 | 0.373 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.094259e-01 | 0.388 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.477950e-01 | 0.459 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.847690e-01 | 0.415 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.895440e-01 | 0.310 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.708064e-01 | 0.567 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.045924e-01 | 0.516 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.047658e-01 | 0.516 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.740100e-01 | 0.562 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.415761e-01 | 0.467 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.415761e-01 | 0.467 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.847690e-01 | 0.415 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.721703e-01 | 0.429 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.745458e-01 | 0.561 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.056694e-01 | 0.296 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.979908e-01 | 0.303 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.762519e-01 | 0.425 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.175985e-01 | 0.286 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 3.066800e-01 | 0.513 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.087975e-01 | 0.388 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.949198e-01 | 0.305 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.920664e-01 | 0.407 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.253159e-01 | 0.280 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.131955e-01 | 0.504 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.131955e-01 | 0.504 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.131955e-01 | 0.504 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.131955e-01 | 0.504 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.035813e-01 | 0.298 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.847690e-01 | 0.415 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.166821e-01 | 0.287 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.363964e-01 | 0.360 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.188252e-01 | 0.285 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.050540e-01 | 0.516 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 5.166821e-01 | 0.287 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.419811e-01 | 0.355 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.333552e-01 | 0.477 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.333552e-01 | 0.477 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.803277e-01 | 0.420 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.640564e-01 | 0.439 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.120909e-01 | 0.291 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.050540e-01 | 0.516 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.782592e-01 | 0.556 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.085396e-01 | 0.389 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.394805e-01 | 0.469 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.400579e-01 | 0.356 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.735187e-01 | 0.563 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.996049e-01 | 0.398 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.686140e-01 | 0.571 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.047658e-01 | 0.516 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.841122e-01 | 0.416 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.841122e-01 | 0.416 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.841122e-01 | 0.416 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.544069e-01 | 0.343 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 4.544069e-01 | 0.343 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.066800e-01 | 0.513 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.001490e-01 | 0.523 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.266828e-01 | 0.370 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.166821e-01 | 0.287 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.166821e-01 | 0.287 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.981166e-01 | 0.526 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 4.670470e-01 | 0.331 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.708108e-01 | 0.431 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.156388e-01 | 0.501 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.287330e-01 | 0.483 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.996049e-01 | 0.398 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.675916e-01 | 0.330 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.692041e-01 | 0.433 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.871639e-01 | 0.312 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.871639e-01 | 0.312 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.739126e-01 | 0.324 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.333552e-01 | 0.477 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.863803e-01 | 0.413 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.950127e-01 | 0.530 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.992495e-01 | 0.302 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.516186e-01 | 0.454 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.684958e-01 | 0.571 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.244608e-01 | 0.280 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.731015e-01 | 0.428 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.236626e-01 | 0.490 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.266828e-01 | 0.370 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.391802e-01 | 0.357 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.638225e-01 | 0.579 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.152316e-01 | 0.501 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.266828e-01 | 0.370 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.266828e-01 | 0.370 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.675916e-01 | 0.330 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.264179e-01 | 0.370 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.254121e-01 | 0.488 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.613313e-01 | 0.442 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.363964e-01 | 0.360 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.323072e-01 | 0.364 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.689279e-01 | 0.570 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.746230e-01 | 0.324 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.740100e-01 | 0.562 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.166821e-01 | 0.287 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.689279e-01 | 0.570 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.235471e-01 | 0.490 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.045370e-01 | 0.393 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.863820e-01 | 0.413 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.670470e-01 | 0.331 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.570583e-01 | 0.447 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.131955e-01 | 0.504 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.944923e-01 | 0.404 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.675916e-01 | 0.330 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.056694e-01 | 0.296 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.156388e-01 | 0.501 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.761115e-01 | 0.425 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.876472e-01 | 0.312 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.101942e-01 | 0.292 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.321017e-01 | 0.479 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.974699e-01 | 0.527 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.400579e-01 | 0.356 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.744290e-01 | 0.324 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.731015e-01 | 0.428 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.321017e-01 | 0.479 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.841122e-01 | 0.416 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.670470e-01 | 0.331 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.363964e-01 | 0.360 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.056694e-01 | 0.296 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.419811e-01 | 0.355 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.837319e-01 | 0.315 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.053368e-01 | 0.392 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.192033e-01 | 0.378 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.415761e-01 | 0.467 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.544069e-01 | 0.343 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.266828e-01 | 0.370 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.333552e-01 | 0.477 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.064100e-01 | 0.295 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.050540e-01 | 0.516 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.418749e-01 | 0.355 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.218347e-01 | 0.282 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.670470e-01 | 0.331 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.363964e-01 | 0.360 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.180925e-01 | 0.379 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.056694e-01 | 0.296 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.394805e-01 | 0.469 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.629609e-01 | 0.334 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.979908e-01 | 0.303 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.266828e-01 | 0.370 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 5.166821e-01 | 0.287 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.721703e-01 | 0.429 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.274862e-01 | 0.278 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.274862e-01 | 0.278 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.274862e-01 | 0.278 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.274862e-01 | 0.278 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.288033e-01 | 0.277 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.323267e-01 | 0.274 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.364303e-01 | 0.270 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.399526e-01 | 0.268 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.423221e-01 | 0.266 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.423221e-01 | 0.266 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.423221e-01 | 0.266 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.424218e-01 | 0.266 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.424218e-01 | 0.266 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.424218e-01 | 0.266 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.424218e-01 | 0.266 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.424218e-01 | 0.266 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.424218e-01 | 0.266 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 5.424218e-01 | 0.266 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.424218e-01 | 0.266 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.468221e-01 | 0.262 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.539963e-01 | 0.256 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.539963e-01 | 0.256 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.539963e-01 | 0.256 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.542162e-01 | 0.256 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.559912e-01 | 0.255 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.559912e-01 | 0.255 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.559912e-01 | 0.255 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.598147e-01 | 0.252 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.618788e-01 | 0.250 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.632486e-01 | 0.249 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.636447e-01 | 0.249 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.663781e-01 | 0.247 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.663781e-01 | 0.247 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.663781e-01 | 0.247 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.687225e-01 | 0.245 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.717832e-01 | 0.243 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.718524e-01 | 0.243 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.718524e-01 | 0.243 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.718524e-01 | 0.243 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.718524e-01 | 0.243 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.718524e-01 | 0.243 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.718524e-01 | 0.243 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.718524e-01 | 0.243 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.718524e-01 | 0.243 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 5.718524e-01 | 0.243 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.718524e-01 | 0.243 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.718524e-01 | 0.243 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.718524e-01 | 0.243 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.718524e-01 | 0.243 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.718524e-01 | 0.243 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.718524e-01 | 0.243 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.718524e-01 | 0.243 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.718524e-01 | 0.243 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.718524e-01 | 0.243 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.718524e-01 | 0.243 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.718524e-01 | 0.243 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.718524e-01 | 0.243 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.718524e-01 | 0.243 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.718524e-01 | 0.243 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.743605e-01 | 0.241 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.772280e-01 | 0.239 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.772280e-01 | 0.239 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.772280e-01 | 0.239 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.772280e-01 | 0.239 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.772280e-01 | 0.239 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.772280e-01 | 0.239 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.772280e-01 | 0.239 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.772280e-01 | 0.239 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.829231e-01 | 0.234 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.838913e-01 | 0.234 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.857776e-01 | 0.232 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.897178e-01 | 0.229 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.899570e-01 | 0.229 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.957841e-01 | 0.225 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.957841e-01 | 0.225 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.957841e-01 | 0.225 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.957841e-01 | 0.225 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.957841e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.964344e-01 | 0.224 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.964344e-01 | 0.224 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.964344e-01 | 0.224 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.998994e-01 | 0.222 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.015769e-01 | 0.221 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.015769e-01 | 0.221 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.024674e-01 | 0.220 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.024674e-01 | 0.220 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.029116e-01 | 0.220 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.041966e-01 | 0.219 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.056399e-01 | 0.218 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.092442e-01 | 0.215 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.097816e-01 | 0.215 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.097816e-01 | 0.215 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.097816e-01 | 0.215 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.100533e-01 | 0.215 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.100533e-01 | 0.215 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.100533e-01 | 0.215 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.100533e-01 | 0.215 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.100533e-01 | 0.215 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.110708e-01 | 0.214 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.123019e-01 | 0.213 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.123019e-01 | 0.213 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.185825e-01 | 0.209 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.191784e-01 | 0.208 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.197699e-01 | 0.208 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.207278e-01 | 0.207 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.207278e-01 | 0.207 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.207278e-01 | 0.207 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.207278e-01 | 0.207 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.207278e-01 | 0.207 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.207278e-01 | 0.207 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.207278e-01 | 0.207 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.207278e-01 | 0.207 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.207278e-01 | 0.207 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.207278e-01 | 0.207 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.207278e-01 | 0.207 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.207278e-01 | 0.207 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.207278e-01 | 0.207 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.207278e-01 | 0.207 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.207278e-01 | 0.207 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.207278e-01 | 0.207 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.207278e-01 | 0.207 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.207278e-01 | 0.207 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.207278e-01 | 0.207 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.207278e-01 | 0.207 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.222202e-01 | 0.206 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.320310e-01 | 0.199 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.340996e-01 | 0.198 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.340996e-01 | 0.198 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.349844e-01 | 0.197 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.349844e-01 | 0.197 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.349844e-01 | 0.197 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.352888e-01 | 0.197 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.389919e-01 | 0.195 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.399762e-01 | 0.194 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.408965e-01 | 0.193 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.408965e-01 | 0.193 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 6.408965e-01 | 0.193 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 6.408965e-01 | 0.193 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 6.408965e-01 | 0.193 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.408965e-01 | 0.193 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.432028e-01 | 0.192 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.444503e-01 | 0.191 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.527259e-01 | 0.185 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.541243e-01 | 0.184 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.550882e-01 | 0.184 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.550882e-01 | 0.184 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.550882e-01 | 0.184 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.561300e-01 | 0.183 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.590284e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.590284e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.590284e-01 | 0.181 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.590284e-01 | 0.181 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.590284e-01 | 0.181 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.628529e-01 | 0.179 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.640264e-01 | 0.178 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.640264e-01 | 0.178 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.640264e-01 | 0.178 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.640264e-01 | 0.178 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.640264e-01 | 0.178 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.640264e-01 | 0.178 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.640264e-01 | 0.178 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.640264e-01 | 0.178 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.640264e-01 | 0.178 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.640264e-01 | 0.178 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.640264e-01 | 0.178 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.640264e-01 | 0.178 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.640264e-01 | 0.178 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.640264e-01 | 0.178 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.640264e-01 | 0.178 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.640264e-01 | 0.178 | 0 | 0 |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | R-HSA-159763 | 6.640264e-01 | 0.178 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.681564e-01 | 0.175 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.681564e-01 | 0.175 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.681564e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.681564e-01 | 0.175 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.697823e-01 | 0.174 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.697823e-01 | 0.174 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.697823e-01 | 0.174 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.697823e-01 | 0.174 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.697823e-01 | 0.174 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.697823e-01 | 0.174 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.697823e-01 | 0.174 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.697823e-01 | 0.174 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.723262e-01 | 0.172 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.723262e-01 | 0.172 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.758233e-01 | 0.170 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.819060e-01 | 0.166 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.819060e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.845325e-01 | 0.165 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.867316e-01 | 0.163 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.873973e-01 | 0.163 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.875661e-01 | 0.163 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.875661e-01 | 0.163 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.884937e-01 | 0.162 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.898961e-01 | 0.161 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.933027e-01 | 0.159 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.945819e-01 | 0.158 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.967554e-01 | 0.157 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.967554e-01 | 0.157 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.967554e-01 | 0.157 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.967554e-01 | 0.157 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.967554e-01 | 0.157 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.967554e-01 | 0.157 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.967554e-01 | 0.157 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.967554e-01 | 0.157 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.004744e-01 | 0.155 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.008580e-01 | 0.154 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.023842e-01 | 0.153 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.023842e-01 | 0.153 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.023842e-01 | 0.153 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.023842e-01 | 0.153 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.023842e-01 | 0.153 | 0 | 0 |
| Opsins | R-HSA-419771 | 7.023842e-01 | 0.153 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.023842e-01 | 0.153 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.023842e-01 | 0.153 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.023842e-01 | 0.153 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.023842e-01 | 0.153 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 7.023842e-01 | 0.153 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.023842e-01 | 0.153 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.023842e-01 | 0.153 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.023842e-01 | 0.153 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.023842e-01 | 0.153 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.023842e-01 | 0.153 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.023842e-01 | 0.153 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 7.023842e-01 | 0.153 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.032077e-01 | 0.153 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.036200e-01 | 0.153 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.036200e-01 | 0.153 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.036200e-01 | 0.153 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.036200e-01 | 0.153 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.036200e-01 | 0.153 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.067873e-01 | 0.151 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.067873e-01 | 0.151 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.067873e-01 | 0.151 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.099221e-01 | 0.149 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.126229e-01 | 0.147 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.130580e-01 | 0.147 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.183112e-01 | 0.144 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.218762e-01 | 0.142 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.218762e-01 | 0.142 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 7.218762e-01 | 0.142 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.218762e-01 | 0.142 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 7.218762e-01 | 0.142 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.218762e-01 | 0.142 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.241822e-01 | 0.140 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.241822e-01 | 0.140 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.253622e-01 | 0.139 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.307331e-01 | 0.136 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.307331e-01 | 0.136 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.307331e-01 | 0.136 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.307331e-01 | 0.136 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.307331e-01 | 0.136 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.307331e-01 | 0.136 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.307331e-01 | 0.136 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.328738e-01 | 0.135 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.360680e-01 | 0.133 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.363647e-01 | 0.133 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.363647e-01 | 0.133 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.363647e-01 | 0.133 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.363647e-01 | 0.133 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.363647e-01 | 0.133 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.363647e-01 | 0.133 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.363647e-01 | 0.133 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.363647e-01 | 0.133 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.363647e-01 | 0.133 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.386284e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.423737e-01 | 0.129 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.436115e-01 | 0.129 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.436115e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.451902e-01 | 0.128 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.452159e-01 | 0.128 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.452159e-01 | 0.128 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.452159e-01 | 0.128 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.452159e-01 | 0.128 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.468948e-01 | 0.127 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.468948e-01 | 0.127 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.475413e-01 | 0.126 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.475631e-01 | 0.126 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.514657e-01 | 0.124 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.526305e-01 | 0.123 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.551439e-01 | 0.122 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.595105e-01 | 0.119 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.597186e-01 | 0.119 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.619332e-01 | 0.118 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.619332e-01 | 0.118 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.634218e-01 | 0.117 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.642312e-01 | 0.117 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.648538e-01 | 0.116 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.650358e-01 | 0.116 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.652454e-01 | 0.116 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.664672e-01 | 0.116 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 7.664672e-01 | 0.116 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.664672e-01 | 0.116 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.664672e-01 | 0.116 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.664672e-01 | 0.116 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.664672e-01 | 0.116 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.664672e-01 | 0.116 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.664672e-01 | 0.116 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.664672e-01 | 0.116 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.664672e-01 | 0.116 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.664672e-01 | 0.116 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.664672e-01 | 0.116 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.664672e-01 | 0.116 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.664672e-01 | 0.116 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.664672e-01 | 0.116 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.664672e-01 | 0.116 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.668536e-01 | 0.115 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.668536e-01 | 0.115 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.668536e-01 | 0.115 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.668536e-01 | 0.115 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.668536e-01 | 0.115 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.678597e-01 | 0.115 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.678597e-01 | 0.115 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.734736e-01 | 0.112 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.745895e-01 | 0.111 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.791778e-01 | 0.108 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.815123e-01 | 0.107 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.837705e-01 | 0.106 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.837705e-01 | 0.106 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.857344e-01 | 0.105 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.868737e-01 | 0.104 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.868737e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.868737e-01 | 0.104 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.868737e-01 | 0.104 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.868737e-01 | 0.104 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.868737e-01 | 0.104 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.868737e-01 | 0.104 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.909291e-01 | 0.102 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.909291e-01 | 0.102 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.926834e-01 | 0.101 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.931340e-01 | 0.101 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.931340e-01 | 0.101 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.931340e-01 | 0.101 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.931340e-01 | 0.101 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.931340e-01 | 0.101 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.931340e-01 | 0.101 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.931340e-01 | 0.101 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.931340e-01 | 0.101 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.931340e-01 | 0.101 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.945359e-01 | 0.100 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.953793e-01 | 0.099 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.953793e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.976240e-01 | 0.098 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.977660e-01 | 0.098 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.977660e-01 | 0.098 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.977660e-01 | 0.098 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.978337e-01 | 0.098 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.993325e-01 | 0.097 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.011650e-01 | 0.096 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.053634e-01 | 0.094 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.053634e-01 | 0.094 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.053634e-01 | 0.094 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.053634e-01 | 0.094 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.061810e-01 | 0.094 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.068672e-01 | 0.093 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.089980e-01 | 0.092 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.121559e-01 | 0.090 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.154026e-01 | 0.089 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.154026e-01 | 0.089 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.159438e-01 | 0.088 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 8.167572e-01 | 0.088 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 8.167572e-01 | 0.088 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 8.167572e-01 | 0.088 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 8.167572e-01 | 0.088 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.167572e-01 | 0.088 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.167572e-01 | 0.088 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.167572e-01 | 0.088 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.167572e-01 | 0.088 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.167572e-01 | 0.088 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.167572e-01 | 0.088 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.167572e-01 | 0.088 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.167572e-01 | 0.088 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.167572e-01 | 0.088 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.178273e-01 | 0.087 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.197809e-01 | 0.086 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.197809e-01 | 0.086 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.198658e-01 | 0.086 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.224111e-01 | 0.085 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.224111e-01 | 0.085 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.224111e-01 | 0.085 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.224111e-01 | 0.085 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.224111e-01 | 0.085 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.224111e-01 | 0.085 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.248055e-01 | 0.084 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.248055e-01 | 0.084 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.262585e-01 | 0.083 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.288442e-01 | 0.082 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.288442e-01 | 0.082 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.302382e-01 | 0.081 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.318684e-01 | 0.080 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.318684e-01 | 0.080 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.318684e-01 | 0.080 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.319740e-01 | 0.080 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.319740e-01 | 0.080 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.326694e-01 | 0.080 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.331565e-01 | 0.079 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.364111e-01 | 0.078 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.376840e-01 | 0.077 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.376840e-01 | 0.077 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.376840e-01 | 0.077 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.376840e-01 | 0.077 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.376840e-01 | 0.077 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.376840e-01 | 0.077 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.376840e-01 | 0.077 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.376840e-01 | 0.077 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.376840e-01 | 0.077 | 0 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 8.376840e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.376957e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.376957e-01 | 0.077 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.381049e-01 | 0.077 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.381111e-01 | 0.077 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.381111e-01 | 0.077 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.381898e-01 | 0.077 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.434712e-01 | 0.074 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.434712e-01 | 0.074 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.446540e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.495443e-01 | 0.071 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.505343e-01 | 0.070 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.506957e-01 | 0.070 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.506957e-01 | 0.070 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.506957e-01 | 0.070 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.525316e-01 | 0.069 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.525316e-01 | 0.069 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.525316e-01 | 0.069 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.532186e-01 | 0.069 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.542984e-01 | 0.068 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.542984e-01 | 0.068 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.545683e-01 | 0.068 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.562219e-01 | 0.067 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.562219e-01 | 0.067 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.562219e-01 | 0.067 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.562219e-01 | 0.067 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.562219e-01 | 0.067 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.562219e-01 | 0.067 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.562219e-01 | 0.067 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.562219e-01 | 0.067 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.562219e-01 | 0.067 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.562219e-01 | 0.067 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.562219e-01 | 0.067 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.562219e-01 | 0.067 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.562219e-01 | 0.067 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.562219e-01 | 0.067 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.583230e-01 | 0.066 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.585035e-01 | 0.066 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.602491e-01 | 0.065 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.621180e-01 | 0.064 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.644821e-01 | 0.063 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.644821e-01 | 0.063 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.657760e-01 | 0.063 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.657760e-01 | 0.063 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.657760e-01 | 0.063 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.657760e-01 | 0.063 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.692846e-01 | 0.061 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.692846e-01 | 0.061 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.726437e-01 | 0.059 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.726437e-01 | 0.059 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.726437e-01 | 0.059 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.726437e-01 | 0.059 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.726437e-01 | 0.059 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.726437e-01 | 0.059 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.726437e-01 | 0.059 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.726437e-01 | 0.059 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.726437e-01 | 0.059 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.729050e-01 | 0.059 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.729050e-01 | 0.059 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.729050e-01 | 0.059 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.751024e-01 | 0.058 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.778214e-01 | 0.057 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.779197e-01 | 0.057 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.779197e-01 | 0.057 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.786305e-01 | 0.056 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.814060e-01 | 0.055 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.829377e-01 | 0.054 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.830268e-01 | 0.054 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.830268e-01 | 0.054 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.830268e-01 | 0.054 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.830268e-01 | 0.054 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.830268e-01 | 0.054 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.858785e-01 | 0.053 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.858785e-01 | 0.053 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.871906e-01 | 0.052 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.871906e-01 | 0.052 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.871906e-01 | 0.052 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.871906e-01 | 0.052 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.871906e-01 | 0.052 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.871906e-01 | 0.052 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.871906e-01 | 0.052 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.871906e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.871906e-01 | 0.052 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.871906e-01 | 0.052 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.871906e-01 | 0.052 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.882518e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.890415e-01 | 0.051 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.890415e-01 | 0.051 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.890415e-01 | 0.051 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.890415e-01 | 0.051 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.890415e-01 | 0.051 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.890415e-01 | 0.051 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.890415e-01 | 0.051 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.898676e-01 | 0.051 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.922581e-01 | 0.050 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.934754e-01 | 0.049 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.934754e-01 | 0.049 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.949161e-01 | 0.048 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.967171e-01 | 0.047 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.977024e-01 | 0.047 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.992163e-01 | 0.046 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.992163e-01 | 0.046 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.992163e-01 | 0.046 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.000767e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.000767e-01 | 0.046 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.000767e-01 | 0.046 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.000767e-01 | 0.046 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.000767e-01 | 0.046 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 9.000767e-01 | 0.046 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.000767e-01 | 0.046 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.000767e-01 | 0.046 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.009069e-01 | 0.045 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.009069e-01 | 0.045 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.009069e-01 | 0.045 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.009069e-01 | 0.045 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.034256e-01 | 0.044 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.048223e-01 | 0.043 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.066923e-01 | 0.043 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.066923e-01 | 0.043 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.073656e-01 | 0.042 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.073656e-01 | 0.042 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.085152e-01 | 0.042 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.085152e-01 | 0.042 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.085152e-01 | 0.042 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.085152e-01 | 0.042 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.085152e-01 | 0.042 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.085152e-01 | 0.042 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.109321e-01 | 0.041 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.114915e-01 | 0.040 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.114915e-01 | 0.040 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.114915e-01 | 0.040 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.114915e-01 | 0.040 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.114915e-01 | 0.040 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.114915e-01 | 0.040 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.114915e-01 | 0.040 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.114915e-01 | 0.040 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.136973e-01 | 0.039 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.138732e-01 | 0.039 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.145633e-01 | 0.039 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.153856e-01 | 0.038 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.153856e-01 | 0.038 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.163481e-01 | 0.038 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.163481e-01 | 0.038 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.170056e-01 | 0.038 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.170056e-01 | 0.038 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.170056e-01 | 0.038 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.170056e-01 | 0.038 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.170056e-01 | 0.038 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.196452e-01 | 0.036 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.197718e-01 | 0.036 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.208667e-01 | 0.036 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.216030e-01 | 0.035 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.216030e-01 | 0.035 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.216030e-01 | 0.035 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.216030e-01 | 0.035 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.216030e-01 | 0.035 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.216030e-01 | 0.035 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.216030e-01 | 0.035 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.242871e-01 | 0.034 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.247507e-01 | 0.034 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.252278e-01 | 0.034 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.260089e-01 | 0.033 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.260089e-01 | 0.033 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.260089e-01 | 0.033 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.277760e-01 | 0.033 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.305597e-01 | 0.031 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.305597e-01 | 0.031 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.305597e-01 | 0.031 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.305597e-01 | 0.031 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.305597e-01 | 0.031 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.315987e-01 | 0.031 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.318100e-01 | 0.031 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.342469e-01 | 0.030 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.344075e-01 | 0.029 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.354262e-01 | 0.029 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.354313e-01 | 0.029 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.368036e-01 | 0.028 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.380929e-01 | 0.028 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.382391e-01 | 0.028 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.384937e-01 | 0.028 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.384937e-01 | 0.028 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.384937e-01 | 0.028 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.384937e-01 | 0.028 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.384937e-01 | 0.028 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.384937e-01 | 0.028 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.384937e-01 | 0.028 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.402262e-01 | 0.027 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.408347e-01 | 0.026 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.408347e-01 | 0.026 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.408347e-01 | 0.026 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.416061e-01 | 0.026 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.440898e-01 | 0.025 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.440898e-01 | 0.025 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.447888e-01 | 0.025 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.455131e-01 | 0.024 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.455216e-01 | 0.024 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.455216e-01 | 0.024 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.455216e-01 | 0.024 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.455216e-01 | 0.024 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.461476e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.482763e-01 | 0.023 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.482763e-01 | 0.023 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.494102e-01 | 0.023 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.504135e-01 | 0.022 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.504135e-01 | 0.022 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.512281e-01 | 0.022 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.517468e-01 | 0.021 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.517468e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.517468e-01 | 0.021 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.517468e-01 | 0.021 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.517468e-01 | 0.021 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.517468e-01 | 0.021 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.520293e-01 | 0.021 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.537643e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.542452e-01 | 0.020 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.542452e-01 | 0.020 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.545105e-01 | 0.020 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.572609e-01 | 0.019 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.572609e-01 | 0.019 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.572609e-01 | 0.019 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.572609e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.572609e-01 | 0.019 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.585292e-01 | 0.018 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.586362e-01 | 0.018 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.586362e-01 | 0.018 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.586362e-01 | 0.018 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.586362e-01 | 0.018 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.586362e-01 | 0.018 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.588011e-01 | 0.018 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.621453e-01 | 0.017 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.621453e-01 | 0.017 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.621453e-01 | 0.017 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.621453e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.626215e-01 | 0.017 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.626215e-01 | 0.017 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.626215e-01 | 0.017 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.629522e-01 | 0.016 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.635282e-01 | 0.016 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.642375e-01 | 0.016 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.642375e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.653856e-01 | 0.015 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.662365e-01 | 0.015 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.662365e-01 | 0.015 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.664717e-01 | 0.015 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.664717e-01 | 0.015 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.664717e-01 | 0.015 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.664717e-01 | 0.015 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.664717e-01 | 0.015 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.664717e-01 | 0.015 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.664717e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.670982e-01 | 0.015 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.676421e-01 | 0.014 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.695137e-01 | 0.013 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.695137e-01 | 0.013 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.703038e-01 | 0.013 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.703038e-01 | 0.013 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.703038e-01 | 0.013 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.703038e-01 | 0.013 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.703038e-01 | 0.013 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.703038e-01 | 0.013 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.711625e-01 | 0.013 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.719968e-01 | 0.012 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.719968e-01 | 0.012 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.724830e-01 | 0.012 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.724830e-01 | 0.012 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.735737e-01 | 0.012 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.736982e-01 | 0.012 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.736982e-01 | 0.012 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.751721e-01 | 0.011 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.751721e-01 | 0.011 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.753157e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.754386e-01 | 0.011 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.755528e-01 | 0.011 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.767047e-01 | 0.010 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.767047e-01 | 0.010 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.767047e-01 | 0.010 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.767047e-01 | 0.010 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.772593e-01 | 0.010 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.776062e-01 | 0.010 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.776131e-01 | 0.010 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.780069e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.782417e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.793677e-01 | 0.009 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.793677e-01 | 0.009 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.793677e-01 | 0.009 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.793677e-01 | 0.009 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.798084e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.798084e-01 | 0.009 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.798084e-01 | 0.009 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.813474e-01 | 0.008 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.817265e-01 | 0.008 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.817265e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.817265e-01 | 0.008 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.818000e-01 | 0.008 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.818000e-01 | 0.008 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.818000e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.818000e-01 | 0.008 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.825558e-01 | 0.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.825558e-01 | 0.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.827282e-01 | 0.008 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.831115e-01 | 0.007 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.836002e-01 | 0.007 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.836002e-01 | 0.007 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.836002e-01 | 0.007 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.838157e-01 | 0.007 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.838157e-01 | 0.007 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.838157e-01 | 0.007 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.840972e-01 | 0.007 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.852079e-01 | 0.006 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.852079e-01 | 0.006 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.852269e-01 | 0.006 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.853883e-01 | 0.006 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.856661e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.860500e-01 | 0.006 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.866960e-01 | 0.006 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.866960e-01 | 0.006 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.873051e-01 | 0.006 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.873051e-01 | 0.006 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.873508e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.880225e-01 | 0.005 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.880225e-01 | 0.005 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.880225e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.887095e-01 | 0.005 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.887567e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.890511e-01 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.891282e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.891990e-01 | 0.005 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.891990e-01 | 0.005 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.892197e-01 | 0.005 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.894100e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.897409e-01 | 0.004 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.900425e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.900425e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.906811e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.907903e-01 | 0.004 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.911157e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.911813e-01 | 0.004 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.911813e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.918185e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.921898e-01 | 0.003 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.921898e-01 | 0.003 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.921898e-01 | 0.003 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.921898e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.921898e-01 | 0.003 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.922439e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.923106e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.923106e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.924847e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.925013e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.925237e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.925906e-01 | 0.003 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.930831e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.930831e-01 | 0.003 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.936569e-01 | 0.003 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.936569e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.938743e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.938743e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.945327e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.945750e-01 | 0.002 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.945750e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.945750e-01 | 0.002 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.945750e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.948779e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.951956e-01 | 0.002 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.951956e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.951956e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.951956e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.951956e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.951956e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.952593e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.953987e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.957453e-01 | 0.002 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.957453e-01 | 0.002 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.957453e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.958208e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.958996e-01 | 0.002 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.961301e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.962320e-01 | 0.002 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.962562e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.966087e-01 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.966087e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.966632e-01 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.966632e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.967143e-01 | 0.001 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.970450e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.970450e-01 | 0.001 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.970450e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.970728e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.972717e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.973163e-01 | 0.001 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.973163e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.973831e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.973831e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.973831e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.973999e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.973999e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.975843e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.975921e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.976187e-01 | 0.001 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.976487e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.978398e-01 | 0.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.979478e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.979478e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.979794e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.979931e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.983034e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.983907e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.984420e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.984420e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.985783e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.985906e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.987380e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.987480e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.989710e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.989946e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.990104e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.991237e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992116e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992287e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.992772e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.992772e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.994654e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994810e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.995230e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.995230e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.995447e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.995757e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.996253e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.996431e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996670e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.996670e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996670e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996830e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997068e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.997068e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997565e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997615e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997701e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997995e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998198e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998294e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998816e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998892e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999009e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999231e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999231e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999319e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999319e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999397e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999466e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999466e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999467e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999557e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999605e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999685e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999705e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999725e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999743e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999744e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999749e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999759e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999784e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999799e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999914e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999915e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999924e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999936e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999939e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999940e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999949e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999981e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999982e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999986e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999987e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999992e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999995e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999996e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999997e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999998e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.992007e-16 | 15.000 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.241229e-13 | 12.906 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.818545e-13 | 12.740 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.323208e-13 | 12.364 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.438183e-13 | 12.191 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.438183e-13 | 12.191 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.020251e-13 | 12.096 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.445288e-12 | 11.840 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.395528e-12 | 11.621 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.579092e-11 | 10.802 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.371903e-11 | 10.472 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.894074e-11 | 10.410 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.536838e-11 | 10.021 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.936524e-10 | 9.713 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.375954e-10 | 9.624 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.704401e-10 | 9.568 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.243152e-10 | 9.372 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.805916e-10 | 9.318 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.172716e-10 | 9.286 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.587639e-10 | 9.253 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.446413e-10 | 9.191 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.339790e-10 | 9.134 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.507618e-10 | 9.124 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.213669e-10 | 9.085 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.161218e-10 | 9.038 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.161218e-10 | 9.038 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.128388e-09 | 8.948 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.197659e-09 | 8.922 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.228527e-09 | 8.911 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.289905e-09 | 8.889 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.657709e-09 | 8.780 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.694394e-09 | 8.771 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.900600e-09 | 8.721 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.845854e-09 | 8.546 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.731612e-09 | 8.428 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.995100e-09 | 8.398 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.922881e-09 | 8.308 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.269190e-09 | 8.278 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.019853e-09 | 8.220 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.493810e-09 | 8.188 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.553431e-09 | 8.184 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.960006e-09 | 8.099 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.342503e-09 | 8.030 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.809191e-09 | 8.008 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.147935e-08 | 7.940 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.147935e-08 | 7.940 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.173046e-08 | 7.931 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.494262e-08 | 7.826 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.918551e-08 | 7.717 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.166854e-08 | 7.664 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.110849e-08 | 7.676 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.453350e-08 | 7.610 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.765705e-08 | 7.558 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.780501e-08 | 7.556 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.555995e-08 | 7.449 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.741925e-08 | 7.427 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.744290e-08 | 7.427 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.799858e-08 | 7.420 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.964752e-08 | 7.402 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.964752e-08 | 7.402 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.499086e-08 | 7.347 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.010117e-08 | 7.300 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.581031e-08 | 7.182 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.714550e-08 | 7.060 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.714550e-08 | 7.060 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.830537e-08 | 7.054 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.380131e-08 | 7.028 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.201925e-08 | 7.036 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.711726e-08 | 7.013 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.080754e-07 | 6.966 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.180973e-07 | 6.928 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.312105e-07 | 6.882 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.334748e-07 | 6.875 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.334748e-07 | 6.875 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.498128e-07 | 6.824 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.693518e-07 | 6.771 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.770400e-07 | 6.752 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.047451e-07 | 6.689 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.169659e-07 | 6.664 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.555151e-07 | 6.593 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.555151e-07 | 6.593 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.527996e-07 | 6.597 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.692353e-07 | 6.570 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.699837e-07 | 6.569 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.873403e-07 | 6.542 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.157523e-07 | 6.501 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.315145e-07 | 6.365 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.324738e-07 | 6.364 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.768408e-07 | 6.322 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.840091e-07 | 6.315 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.998006e-07 | 6.301 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.085585e-07 | 6.216 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.500610e-07 | 6.187 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.186786e-07 | 6.143 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.248958e-07 | 6.084 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.113754e-06 | 5.953 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.194862e-06 | 5.923 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.324664e-06 | 5.878 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.343080e-06 | 5.872 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.447797e-06 | 5.839 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.595665e-06 | 5.797 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.600817e-06 | 5.796 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.907206e-06 | 5.720 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.907206e-06 | 5.720 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.907206e-06 | 5.720 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.907206e-06 | 5.720 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.955510e-06 | 5.709 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.072955e-06 | 5.683 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.230708e-06 | 5.652 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.311971e-06 | 5.636 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.479897e-06 | 5.606 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.347836e-06 | 5.629 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.494306e-06 | 5.603 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.571595e-06 | 5.590 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.663362e-06 | 5.575 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.676256e-06 | 5.572 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.676256e-06 | 5.572 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.758364e-06 | 5.559 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.945669e-06 | 5.531 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.242742e-06 | 5.489 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.373460e-06 | 5.472 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.395349e-06 | 5.469 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.544566e-06 | 5.450 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.655735e-06 | 5.437 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.061710e-06 | 5.391 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.154391e-06 | 5.381 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.717148e-06 | 5.326 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.740756e-06 | 5.324 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.376518e-06 | 5.269 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.396681e-06 | 5.268 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.070091e-06 | 5.217 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.651377e-06 | 5.248 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.651377e-06 | 5.248 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.070091e-06 | 5.217 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.636303e-06 | 5.178 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.025848e-06 | 5.153 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.088229e-06 | 5.149 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.247247e-06 | 5.140 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.445726e-06 | 5.128 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.586743e-06 | 5.120 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.643784e-06 | 5.117 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.754506e-06 | 5.110 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.327598e-06 | 5.079 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.016053e-05 | 4.993 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.028820e-05 | 4.988 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.165507e-05 | 4.933 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.302450e-05 | 4.885 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.250225e-05 | 4.903 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.415662e-05 | 4.849 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.721095e-05 | 4.764 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.777403e-05 | 4.750 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.820223e-05 | 4.740 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.858094e-05 | 4.731 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.858094e-05 | 4.731 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.984228e-05 | 4.702 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.997383e-05 | 4.700 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.091151e-05 | 4.680 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.274961e-05 | 4.643 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.323579e-05 | 4.634 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.460214e-05 | 4.609 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.567560e-05 | 4.590 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.007118e-05 | 4.522 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.992820e-05 | 4.524 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.042314e-05 | 4.517 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.084652e-05 | 4.511 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.096449e-05 | 4.509 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.316496e-05 | 4.479 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.327667e-05 | 4.478 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.494645e-05 | 4.457 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.841566e-05 | 4.415 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.841566e-05 | 4.415 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.142014e-05 | 4.383 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.314439e-05 | 4.365 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.314439e-05 | 4.365 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.314439e-05 | 4.365 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.450853e-05 | 4.352 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.459406e-05 | 4.351 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.469115e-05 | 4.350 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.041920e-05 | 4.297 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.792007e-05 | 4.319 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.792007e-05 | 4.319 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.798617e-05 | 4.319 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.041920e-05 | 4.297 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.749511e-05 | 4.323 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.635793e-05 | 4.334 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.195801e-05 | 4.284 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.201863e-05 | 4.284 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.232437e-05 | 4.281 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.387312e-05 | 4.269 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.652187e-05 | 4.248 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.559460e-05 | 4.183 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.083625e-05 | 4.150 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.311998e-05 | 4.136 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.324017e-05 | 4.135 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.611797e-05 | 4.119 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.632103e-05 | 4.117 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.769449e-05 | 4.110 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.769449e-05 | 4.110 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.769449e-05 | 4.110 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.785595e-05 | 4.109 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.235777e-05 | 4.084 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.913858e-05 | 4.050 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.652436e-05 | 4.063 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.547623e-05 | 4.068 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.171884e-05 | 4.038 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.739889e-05 | 4.011 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.001883e-04 | 3.999 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.029053e-04 | 3.988 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.029053e-04 | 3.988 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.043673e-04 | 3.981 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.047799e-04 | 3.980 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.104668e-04 | 3.957 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.104668e-04 | 3.957 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.166070e-04 | 3.933 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.207655e-04 | 3.918 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.288866e-04 | 3.890 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.288866e-04 | 3.890 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.362079e-04 | 3.866 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.401268e-04 | 3.853 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.532862e-04 | 3.814 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.626512e-04 | 3.789 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.638877e-04 | 3.785 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.830360e-04 | 3.737 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.726003e-04 | 3.763 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.910260e-04 | 3.719 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.796496e-04 | 3.746 | 0 | 0 |
| Translation | R-HSA-72766 | 1.800228e-04 | 3.745 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.935955e-04 | 3.713 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.725243e-04 | 3.763 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.840112e-04 | 3.735 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.699909e-04 | 3.770 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.815054e-04 | 3.741 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.910260e-04 | 3.719 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.080198e-04 | 3.682 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.125394e-04 | 3.673 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.485448e-04 | 3.605 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.485448e-04 | 3.605 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.593598e-04 | 3.586 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.794088e-04 | 3.554 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.794088e-04 | 3.554 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.858888e-04 | 3.544 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.858888e-04 | 3.544 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.891979e-04 | 3.539 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.940513e-04 | 3.532 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.954969e-04 | 3.529 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.007609e-04 | 3.522 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.151679e-04 | 3.501 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.205584e-04 | 3.494 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.255735e-04 | 3.487 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.255735e-04 | 3.487 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.330656e-04 | 3.477 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.415504e-04 | 3.467 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.415504e-04 | 3.467 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.415504e-04 | 3.467 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.415641e-04 | 3.467 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.422020e-04 | 3.466 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.436424e-04 | 3.464 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.445973e-04 | 3.463 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.465896e-04 | 3.460 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.888048e-04 | 3.410 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.963537e-04 | 3.402 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.029987e-04 | 3.395 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.029987e-04 | 3.395 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.166919e-04 | 3.380 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.166919e-04 | 3.380 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.191456e-04 | 3.378 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.457252e-04 | 3.351 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.577016e-04 | 3.339 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.813762e-04 | 3.318 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.291857e-04 | 3.276 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.516427e-04 | 3.258 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.816206e-04 | 3.317 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.597434e-04 | 3.337 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.728546e-04 | 3.325 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.955264e-04 | 3.305 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.659284e-04 | 3.247 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.659284e-04 | 3.247 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.680334e-04 | 3.246 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.228643e-04 | 3.206 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.244226e-04 | 3.205 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.397422e-04 | 3.194 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.406206e-04 | 3.193 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.406206e-04 | 3.193 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.406206e-04 | 3.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.406206e-04 | 3.193 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.840968e-04 | 3.165 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.173711e-04 | 3.144 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.173711e-04 | 3.144 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.173711e-04 | 3.144 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.283325e-04 | 3.138 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.352318e-04 | 3.134 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.352318e-04 | 3.134 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.406837e-04 | 3.130 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.577054e-04 | 3.120 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.699814e-04 | 3.114 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.699814e-04 | 3.114 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.699814e-04 | 3.114 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.924539e-04 | 3.101 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.310278e-04 | 3.080 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.353788e-04 | 3.078 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.685042e-04 | 3.061 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.800043e-04 | 3.056 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.800043e-04 | 3.056 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.932440e-04 | 3.049 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.087529e-04 | 3.042 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.311003e-04 | 3.031 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.422348e-04 | 3.026 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.488757e-04 | 3.023 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.499210e-04 | 3.022 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.528113e-04 | 3.021 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.739632e-04 | 3.011 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.771341e-04 | 3.010 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.912152e-04 | 3.004 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.015136e-03 | 2.993 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.038154e-03 | 2.984 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.050051e-03 | 2.979 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.065749e-03 | 2.972 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.081345e-03 | 2.966 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.100029e-03 | 2.959 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.198908e-03 | 2.921 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.301730e-03 | 2.885 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.371059e-03 | 2.863 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.342164e-03 | 2.872 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.298153e-03 | 2.887 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.298153e-03 | 2.887 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.397582e-03 | 2.855 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.406384e-03 | 2.852 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.182193e-03 | 2.927 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.301730e-03 | 2.885 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.272720e-03 | 2.895 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.272720e-03 | 2.895 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.429721e-03 | 2.845 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.446743e-03 | 2.840 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.500228e-03 | 2.824 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.500228e-03 | 2.824 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.547213e-03 | 2.810 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.567480e-03 | 2.805 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.634582e-03 | 2.787 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.634582e-03 | 2.787 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.653447e-03 | 2.782 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.721864e-03 | 2.764 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.721864e-03 | 2.764 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.787653e-03 | 2.748 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.868570e-03 | 2.728 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.868570e-03 | 2.728 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.880054e-03 | 2.726 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.901252e-03 | 2.721 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.923569e-03 | 2.716 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.925565e-03 | 2.715 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.934570e-03 | 2.713 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.066659e-03 | 2.685 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.086559e-03 | 2.681 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.103422e-03 | 2.677 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.103422e-03 | 2.677 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.118326e-03 | 2.674 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.181008e-03 | 2.661 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.181008e-03 | 2.661 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.287055e-03 | 2.641 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.293736e-03 | 2.639 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.435377e-03 | 2.613 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.451337e-03 | 2.611 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.481667e-03 | 2.605 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.527957e-03 | 2.597 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.630002e-03 | 2.580 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.630974e-03 | 2.580 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.630974e-03 | 2.580 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.703801e-03 | 2.568 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.749410e-03 | 2.561 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.749410e-03 | 2.561 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.848420e-03 | 2.545 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.938640e-03 | 2.532 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.938640e-03 | 2.532 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.058106e-03 | 2.515 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.095885e-03 | 2.509 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.125019e-03 | 2.505 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.275383e-03 | 2.485 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.344608e-03 | 2.476 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.344608e-03 | 2.476 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.469213e-03 | 2.460 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.469213e-03 | 2.460 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.541556e-03 | 2.451 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.623163e-03 | 2.441 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.677353e-03 | 2.434 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.858361e-03 | 2.414 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.858361e-03 | 2.414 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.871053e-03 | 2.412 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.877988e-03 | 2.411 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.879148e-03 | 2.411 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.879148e-03 | 2.411 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.925318e-03 | 2.406 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.991014e-03 | 2.399 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.032944e-03 | 2.394 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.032944e-03 | 2.394 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.043525e-03 | 2.393 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.099131e-03 | 2.387 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.202035e-03 | 2.377 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.227780e-03 | 2.374 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.805607e-03 | 2.318 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.805607e-03 | 2.318 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.382276e-03 | 2.358 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.722635e-03 | 2.326 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.722635e-03 | 2.326 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.722635e-03 | 2.326 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.894215e-03 | 2.310 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.894215e-03 | 2.310 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.980418e-03 | 2.303 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.351783e-03 | 2.272 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.806353e-03 | 2.318 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.806353e-03 | 2.318 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.722635e-03 | 2.326 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.444674e-03 | 2.352 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.382276e-03 | 2.358 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.100686e-03 | 2.292 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.382276e-03 | 2.358 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.382276e-03 | 2.358 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.840326e-03 | 2.315 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.669591e-03 | 2.246 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.089002e-03 | 2.293 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.739034e-03 | 2.241 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.415385e-03 | 2.355 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.547202e-03 | 2.342 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.314283e-03 | 2.365 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.669591e-03 | 2.246 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.832112e-03 | 2.234 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.237311e-03 | 2.205 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.280772e-03 | 2.202 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.373853e-03 | 2.196 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.541045e-03 | 2.184 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.639883e-03 | 2.178 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.762851e-03 | 2.170 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.762851e-03 | 2.170 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.762851e-03 | 2.170 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.864234e-03 | 2.163 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.889163e-03 | 2.162 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.960605e-03 | 2.157 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.161921e-03 | 2.145 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.211456e-03 | 2.142 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.233877e-03 | 2.141 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.327544e-03 | 2.135 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.327544e-03 | 2.135 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.545001e-03 | 2.122 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.613917e-03 | 2.118 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.613917e-03 | 2.118 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.182476e-03 | 2.087 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.667714e-03 | 2.062 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.722277e-03 | 2.059 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.907343e-03 | 2.050 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.126563e-03 | 2.040 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.230153e-03 | 2.035 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.230153e-03 | 2.035 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.359846e-03 | 2.029 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.488755e-03 | 2.023 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.632567e-03 | 2.016 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.004905e-02 | 1.998 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.004905e-02 | 1.998 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.014851e-02 | 1.994 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.014851e-02 | 1.994 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.046593e-02 | 1.980 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.046593e-02 | 1.980 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.046593e-02 | 1.980 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.068931e-02 | 1.971 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.069629e-02 | 1.971 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.069629e-02 | 1.971 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.069629e-02 | 1.971 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.083284e-02 | 1.965 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.094584e-02 | 1.961 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.163302e-02 | 1.934 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.163302e-02 | 1.934 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.177339e-02 | 1.929 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.214616e-02 | 1.916 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.242248e-02 | 1.906 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.242248e-02 | 1.906 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.251208e-02 | 1.903 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.255120e-02 | 1.901 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.316800e-02 | 1.880 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.316800e-02 | 1.880 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.330295e-02 | 1.876 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.362490e-02 | 1.866 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.370946e-02 | 1.863 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.370946e-02 | 1.863 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.370946e-02 | 1.863 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.370946e-02 | 1.863 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.370946e-02 | 1.863 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.398134e-02 | 1.854 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.415083e-02 | 1.849 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.420107e-02 | 1.848 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.420107e-02 | 1.848 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.500192e-02 | 1.824 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.522186e-02 | 1.818 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.522186e-02 | 1.818 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.587156e-02 | 1.799 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.587156e-02 | 1.799 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.591492e-02 | 1.798 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.591492e-02 | 1.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.591492e-02 | 1.798 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.591492e-02 | 1.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.591492e-02 | 1.798 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.591492e-02 | 1.798 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.600045e-02 | 1.796 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.600045e-02 | 1.796 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.600343e-02 | 1.796 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.600343e-02 | 1.796 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.600343e-02 | 1.796 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.600343e-02 | 1.796 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.604663e-02 | 1.795 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.604663e-02 | 1.795 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.604663e-02 | 1.795 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.616214e-02 | 1.792 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.616214e-02 | 1.792 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.616214e-02 | 1.792 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.632369e-02 | 1.787 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.733390e-02 | 1.761 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.757695e-02 | 1.755 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.757695e-02 | 1.755 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.763234e-02 | 1.754 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.763234e-02 | 1.754 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.808786e-02 | 1.743 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.827372e-02 | 1.738 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.827372e-02 | 1.738 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.907098e-02 | 1.720 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.948346e-02 | 1.710 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.948346e-02 | 1.710 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.948346e-02 | 1.710 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.948346e-02 | 1.710 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.023833e-02 | 1.694 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.023833e-02 | 1.694 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.023833e-02 | 1.694 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.183745e-02 | 1.661 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.183745e-02 | 1.661 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.875580e-02 | 1.541 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.446037e-02 | 1.612 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.996553e-02 | 1.700 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.996553e-02 | 1.700 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.996553e-02 | 1.700 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.412320e-02 | 1.618 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.412320e-02 | 1.618 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.365180e-02 | 1.626 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.365180e-02 | 1.626 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.718410e-02 | 1.566 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.718410e-02 | 1.566 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.718410e-02 | 1.566 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.092959e-02 | 1.679 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.346660e-02 | 1.630 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.937285e-02 | 1.532 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.937285e-02 | 1.532 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.040197e-02 | 1.690 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.798018e-02 | 1.553 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.882311e-02 | 1.540 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.385236e-02 | 1.622 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.183745e-02 | 1.661 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.875580e-02 | 1.541 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.718410e-02 | 1.566 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.023833e-02 | 1.694 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.875580e-02 | 1.541 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.702700e-02 | 1.568 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.882311e-02 | 1.540 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.183745e-02 | 1.661 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.875580e-02 | 1.541 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.546949e-02 | 1.594 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.566473e-02 | 1.591 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.636070e-02 | 1.579 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.346660e-02 | 1.630 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.861931e-02 | 1.543 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.183745e-02 | 1.661 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.365180e-02 | 1.626 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.950139e-02 | 1.530 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.950139e-02 | 1.530 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.998733e-02 | 1.523 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.998733e-02 | 1.523 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.999421e-02 | 1.523 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.018783e-02 | 1.520 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.018783e-02 | 1.520 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.018783e-02 | 1.520 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.018783e-02 | 1.520 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.037282e-02 | 1.518 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.054824e-02 | 1.515 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.054824e-02 | 1.515 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.056322e-02 | 1.515 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.119504e-02 | 1.506 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.206219e-02 | 1.494 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.268628e-02 | 1.486 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.294943e-02 | 1.482 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.325637e-02 | 1.478 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.365599e-02 | 1.473 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.365599e-02 | 1.473 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.408807e-02 | 1.467 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.408807e-02 | 1.467 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.434440e-02 | 1.464 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.434440e-02 | 1.464 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.434440e-02 | 1.464 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.434440e-02 | 1.464 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.531167e-02 | 1.452 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.531167e-02 | 1.452 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.531167e-02 | 1.452 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.543234e-02 | 1.451 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.669347e-02 | 1.435 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.669347e-02 | 1.435 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.669347e-02 | 1.435 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.669347e-02 | 1.435 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.669347e-02 | 1.435 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.669347e-02 | 1.435 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.683556e-02 | 1.434 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.683556e-02 | 1.434 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.683556e-02 | 1.434 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.769851e-02 | 1.424 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.797086e-02 | 1.421 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.845335e-02 | 1.415 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.845335e-02 | 1.415 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.911304e-02 | 1.408 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.993249e-02 | 1.399 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.993249e-02 | 1.399 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.107497e-02 | 1.386 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.171735e-02 | 1.380 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.181783e-02 | 1.379 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.181783e-02 | 1.379 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.181783e-02 | 1.379 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.181783e-02 | 1.379 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.219488e-02 | 1.375 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.288440e-02 | 1.368 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.288440e-02 | 1.368 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.324716e-02 | 1.364 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.399710e-02 | 1.357 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.399710e-02 | 1.357 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.399710e-02 | 1.357 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.416149e-02 | 1.355 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.471001e-02 | 1.350 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.493934e-02 | 1.347 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.571155e-02 | 1.340 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.571155e-02 | 1.340 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.764588e-02 | 1.322 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.764588e-02 | 1.322 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.764588e-02 | 1.322 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.921305e-02 | 1.308 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.982187e-02 | 1.303 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.010876e-02 | 1.300 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.211074e-02 | 1.283 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.211074e-02 | 1.283 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.211074e-02 | 1.283 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.211074e-02 | 1.283 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.211074e-02 | 1.283 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.211074e-02 | 1.283 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.211074e-02 | 1.283 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.247160e-02 | 1.280 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.247160e-02 | 1.280 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.247160e-02 | 1.280 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.247160e-02 | 1.280 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.344293e-02 | 1.272 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.344293e-02 | 1.272 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.344293e-02 | 1.272 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.505591e-02 | 1.259 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.562227e-02 | 1.255 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.562227e-02 | 1.255 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.611466e-02 | 1.251 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 5.626512e-02 | 1.250 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.652297e-02 | 1.248 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.652297e-02 | 1.248 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.818797e-02 | 1.235 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.912131e-02 | 1.228 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.912131e-02 | 1.228 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.946152e-02 | 1.226 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.962675e-02 | 1.225 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.103877e-02 | 1.214 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.111744e-02 | 1.214 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.111744e-02 | 1.214 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.351584e-02 | 1.197 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.626652e-02 | 1.179 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.811087e-02 | 1.167 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.811087e-02 | 1.167 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.811087e-02 | 1.167 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.811087e-02 | 1.167 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.941119e-02 | 1.159 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.941119e-02 | 1.159 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.958021e-02 | 1.158 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.012379e-02 | 1.154 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.012379e-02 | 1.154 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.077822e-02 | 1.150 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.077822e-02 | 1.150 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.077822e-02 | 1.150 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.077822e-02 | 1.150 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.390962e-02 | 1.131 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.516104e-02 | 1.124 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.602630e-02 | 1.119 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.602630e-02 | 1.119 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.662296e-02 | 1.116 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.662296e-02 | 1.116 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.832274e-02 | 1.106 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.082397e-02 | 1.092 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.082397e-02 | 1.092 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.131913e-02 | 1.090 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.131913e-02 | 1.090 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.131913e-02 | 1.090 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.205045e-02 | 1.086 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.220083e-02 | 1.085 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 8.271518e-02 | 1.082 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.347842e-02 | 1.078 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.347842e-02 | 1.078 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.348323e-02 | 1.078 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.348323e-02 | 1.078 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.730727e-01 | 0.762 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.730727e-01 | 0.762 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.730727e-01 | 0.762 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.730727e-01 | 0.762 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.730727e-01 | 0.762 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.730727e-01 | 0.762 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 1.730727e-01 | 0.762 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.730727e-01 | 0.762 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.121251e-01 | 0.950 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.121251e-01 | 0.950 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.121251e-01 | 0.950 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.437416e-01 | 0.842 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 1.437416e-01 | 0.842 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 1.437416e-01 | 0.842 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.872763e-02 | 1.052 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.077356e-01 | 0.968 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.077356e-01 | 0.968 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.077356e-01 | 0.968 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.077356e-01 | 0.968 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.281600e-01 | 0.892 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.281600e-01 | 0.892 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.281600e-01 | 0.892 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.498266e-01 | 0.824 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.094402e-01 | 0.961 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.252265e-01 | 0.902 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.725592e-01 | 0.763 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.047335e-01 | 0.980 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.175566e-01 | 0.930 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.797406e-02 | 1.009 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.797406e-02 | 1.009 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.797406e-02 | 1.009 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.797406e-02 | 1.009 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.086920e-01 | 0.964 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.086920e-01 | 0.964 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.452718e-01 | 0.838 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.452718e-01 | 0.838 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.452718e-01 | 0.838 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.318324e-01 | 0.880 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.600864e-01 | 0.796 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.195017e-01 | 0.923 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.686023e-01 | 0.773 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.621650e-01 | 0.790 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.195017e-01 | 0.923 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.047335e-01 | 0.980 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.642868e-01 | 0.784 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.135500e-02 | 1.039 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.135500e-02 | 1.039 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.642868e-01 | 0.784 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.642868e-01 | 0.784 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.318324e-01 | 0.880 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.784674e-02 | 1.056 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.195017e-01 | 0.923 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.094402e-01 | 0.961 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.437416e-01 | 0.842 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.281600e-01 | 0.892 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.281600e-01 | 0.892 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.461847e-02 | 1.024 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.310817e-01 | 0.882 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.571040e-01 | 0.804 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.419078e-01 | 0.848 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.505926e-01 | 0.822 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.367845e-01 | 0.864 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.269117e-01 | 0.896 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.269117e-01 | 0.896 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.269117e-01 | 0.896 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.576422e-01 | 0.802 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.383553e-01 | 0.859 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.437416e-01 | 0.842 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.281600e-01 | 0.892 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.725592e-01 | 0.763 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.367845e-01 | 0.864 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.072037e-01 | 0.970 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.135500e-02 | 1.039 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.470319e-01 | 0.833 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.174240e-01 | 0.930 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.461847e-02 | 1.024 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.252265e-01 | 0.902 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.077356e-01 | 0.968 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.204014e-01 | 0.919 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.730727e-01 | 0.762 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.121251e-01 | 0.950 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.437416e-01 | 0.842 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.077356e-01 | 0.968 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.594093e-01 | 0.797 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.310817e-01 | 0.882 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.918607e-02 | 1.050 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.367845e-01 | 0.864 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.270058e-01 | 0.896 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.465394e-01 | 0.834 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.537803e-01 | 0.813 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.419078e-01 | 0.848 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.195017e-01 | 0.923 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.391487e-01 | 0.857 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.086920e-01 | 0.964 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.199845e-01 | 0.921 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.963891e-02 | 1.002 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.230586e-01 | 0.910 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.264503e-02 | 1.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.047335e-01 | 0.980 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.704764e-01 | 0.768 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.174240e-01 | 0.930 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.086920e-01 | 0.964 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.367845e-01 | 0.864 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.600864e-01 | 0.796 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.310817e-01 | 0.882 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.383610e-01 | 0.859 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 1.310817e-01 | 0.882 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.765128e-02 | 1.057 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.437416e-01 | 0.842 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.175566e-01 | 0.930 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.571040e-01 | 0.804 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.063934e-02 | 1.043 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.367845e-01 | 0.864 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.324322e-01 | 0.878 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.047335e-01 | 0.980 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.686023e-01 | 0.773 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.094402e-01 | 0.961 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.175566e-01 | 0.930 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.135500e-02 | 1.039 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.135500e-02 | 1.039 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.315010e-01 | 0.881 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.393221e-01 | 0.856 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.175566e-01 | 0.930 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.544674e-01 | 0.811 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.033222e-01 | 0.986 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.385951e-01 | 0.858 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.188324e-01 | 0.925 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.264503e-02 | 1.033 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.419078e-01 | 0.848 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.188324e-01 | 0.925 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.188324e-01 | 0.925 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.188324e-01 | 0.925 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.188324e-01 | 0.925 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.442137e-01 | 0.841 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.918607e-02 | 1.050 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.240916e-01 | 0.906 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.072305e-01 | 0.970 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.255002e-01 | 0.901 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.264503e-02 | 1.033 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.252265e-01 | 0.902 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.918607e-02 | 1.050 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.825718e-02 | 1.008 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.594093e-01 | 0.797 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.437416e-01 | 0.842 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.746119e-01 | 0.758 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.754819e-01 | 0.756 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 1.769239e-01 | 0.752 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.769239e-01 | 0.752 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.769239e-01 | 0.752 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.769239e-01 | 0.752 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.769239e-01 | 0.752 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.769239e-01 | 0.752 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.769239e-01 | 0.752 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.776522e-01 | 0.750 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.778318e-01 | 0.750 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 1.794785e-01 | 0.746 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.843021e-01 | 0.734 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.891182e-01 | 0.723 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.914123e-01 | 0.718 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.914123e-01 | 0.718 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.915791e-01 | 0.718 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.915791e-01 | 0.718 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.923539e-01 | 0.716 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.961838e-01 | 0.707 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.961838e-01 | 0.707 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.961838e-01 | 0.707 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.965555e-01 | 0.707 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.985507e-01 | 0.702 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.985507e-01 | 0.702 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.985507e-01 | 0.702 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.020735e-01 | 0.694 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.026037e-01 | 0.693 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.055867e-01 | 0.687 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.078299e-01 | 0.682 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.083542e-01 | 0.681 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.111286e-01 | 0.675 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.111286e-01 | 0.675 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.111286e-01 | 0.675 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.111286e-01 | 0.675 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.111286e-01 | 0.675 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.111286e-01 | 0.675 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.131903e-01 | 0.671 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.131903e-01 | 0.671 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.153584e-01 | 0.667 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.160368e-01 | 0.665 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.160368e-01 | 0.665 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.160368e-01 | 0.665 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.160368e-01 | 0.665 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.161976e-01 | 0.665 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.210225e-01 | 0.656 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.246854e-01 | 0.648 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.246854e-01 | 0.648 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.360134e-01 | 0.627 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.360134e-01 | 0.627 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.419289e-01 | 0.616 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.419289e-01 | 0.616 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.419289e-01 | 0.616 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.428080e-01 | 0.615 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.428080e-01 | 0.615 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.428080e-01 | 0.615 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.428218e-01 | 0.615 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.454395e-01 | 0.610 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.458984e-01 | 0.609 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.458984e-01 | 0.609 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.458984e-01 | 0.609 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.458984e-01 | 0.609 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.458984e-01 | 0.609 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.458984e-01 | 0.609 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.458984e-01 | 0.609 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 2.458984e-01 | 0.609 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.458984e-01 | 0.609 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.458984e-01 | 0.609 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.480358e-01 | 0.605 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.480358e-01 | 0.605 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.480358e-01 | 0.605 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.480358e-01 | 0.605 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.480358e-01 | 0.605 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.480358e-01 | 0.605 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.480358e-01 | 0.605 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.500908e-01 | 0.602 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.500908e-01 | 0.602 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.524980e-01 | 0.598 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.525457e-01 | 0.598 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.564035e-01 | 0.591 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.564035e-01 | 0.591 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.574447e-01 | 0.589 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.595099e-01 | 0.586 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.669693e-01 | 0.574 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.689963e-01 | 0.570 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.707553e-01 | 0.567 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.707553e-01 | 0.567 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.707553e-01 | 0.567 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.707553e-01 | 0.567 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.749889e-01 | 0.561 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.749889e-01 | 0.561 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.771267e-01 | 0.557 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.771267e-01 | 0.557 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.771267e-01 | 0.557 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.807056e-01 | 0.552 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.808499e-01 | 0.552 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.808499e-01 | 0.552 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.808499e-01 | 0.552 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.808499e-01 | 0.552 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 2.808499e-01 | 0.552 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.808499e-01 | 0.552 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.808499e-01 | 0.552 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.808499e-01 | 0.552 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.858695e-01 | 0.544 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.858760e-01 | 0.544 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.858760e-01 | 0.544 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.898578e-01 | 0.538 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.910762e-01 | 0.536 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.954837e-01 | 0.529 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.963350e-01 | 0.528 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.963350e-01 | 0.528 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.963350e-01 | 0.528 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.963350e-01 | 0.528 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.963350e-01 | 0.528 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.963350e-01 | 0.528 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.981050e-01 | 0.526 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.006206e-01 | 0.522 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.075505e-01 | 0.512 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.137776e-01 | 0.503 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.137776e-01 | 0.503 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.156647e-01 | 0.501 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.156647e-01 | 0.501 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.156647e-01 | 0.501 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.156647e-01 | 0.501 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.156647e-01 | 0.501 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.156647e-01 | 0.501 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.156647e-01 | 0.501 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.156647e-01 | 0.501 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.156647e-01 | 0.501 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.162074e-01 | 0.500 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.162074e-01 | 0.500 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.162074e-01 | 0.500 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.162074e-01 | 0.500 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.162074e-01 | 0.500 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.162074e-01 | 0.500 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.162074e-01 | 0.500 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.162074e-01 | 0.500 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.162074e-01 | 0.500 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.162074e-01 | 0.500 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.189616e-01 | 0.496 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.220453e-01 | 0.492 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.237732e-01 | 0.490 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.251311e-01 | 0.488 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.322119e-01 | 0.479 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.352963e-01 | 0.475 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.352963e-01 | 0.475 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.352963e-01 | 0.475 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.403147e-01 | 0.468 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.405287e-01 | 0.468 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.441452e-01 | 0.463 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.477638e-01 | 0.459 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.477638e-01 | 0.459 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.500807e-01 | 0.456 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.500807e-01 | 0.456 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.500807e-01 | 0.456 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.500807e-01 | 0.456 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.500807e-01 | 0.456 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.507398e-01 | 0.455 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.556883e-01 | 0.449 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.556883e-01 | 0.449 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.556883e-01 | 0.449 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.556917e-01 | 0.449 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.618336e-01 | 0.441 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.618336e-01 | 0.441 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.664543e-01 | 0.436 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.667286e-01 | 0.436 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.693164e-01 | 0.433 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.726676e-01 | 0.429 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.733794e-01 | 0.428 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.733794e-01 | 0.428 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.733794e-01 | 0.428 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.733794e-01 | 0.428 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.736174e-01 | 0.428 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.765079e-01 | 0.424 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.782023e-01 | 0.422 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.782023e-01 | 0.422 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.782023e-01 | 0.422 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.782023e-01 | 0.422 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.782023e-01 | 0.422 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.782023e-01 | 0.422 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.782023e-01 | 0.422 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.782023e-01 | 0.422 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.831132e-01 | 0.417 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.831132e-01 | 0.417 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.831132e-01 | 0.417 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.831132e-01 | 0.417 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.838842e-01 | 0.416 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.838842e-01 | 0.416 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.838842e-01 | 0.416 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.869253e-01 | 0.412 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.869253e-01 | 0.412 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.878986e-01 | 0.411 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.909636e-01 | 0.408 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.914183e-01 | 0.407 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.985664e-01 | 0.399 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.987914e-01 | 0.399 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.987914e-01 | 0.399 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.987914e-01 | 0.399 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.987914e-01 | 0.399 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.989827e-01 | 0.399 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 4.020757e-01 | 0.396 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.043071e-01 | 0.393 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.067076e-01 | 0.391 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.070021e-01 | 0.390 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.070021e-01 | 0.390 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.098770e-01 | 0.387 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.113316e-01 | 0.386 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.160626e-01 | 0.381 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.169035e-01 | 0.380 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.169035e-01 | 0.380 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.169035e-01 | 0.380 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.181066e-01 | 0.379 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.183234e-01 | 0.378 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.183234e-01 | 0.378 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.239102e-01 | 0.373 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.239102e-01 | 0.373 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.239102e-01 | 0.373 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.239102e-01 | 0.373 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.249166e-01 | 0.372 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.253592e-01 | 0.371 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.253592e-01 | 0.371 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.345799e-01 | 0.362 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.345799e-01 | 0.362 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.345799e-01 | 0.362 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.345799e-01 | 0.362 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.345799e-01 | 0.362 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.345799e-01 | 0.362 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.345799e-01 | 0.362 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.345799e-01 | 0.362 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.345799e-01 | 0.362 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.345799e-01 | 0.362 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.345799e-01 | 0.362 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.425957e-01 | 0.354 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.432764e-01 | 0.353 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.432764e-01 | 0.353 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.432764e-01 | 0.353 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.451820e-01 | 0.351 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.462175e-01 | 0.350 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.462175e-01 | 0.350 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.462175e-01 | 0.350 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.483779e-01 | 0.348 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.486563e-01 | 0.348 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.490030e-01 | 0.348 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.490030e-01 | 0.348 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.490030e-01 | 0.348 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.490030e-01 | 0.348 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.490030e-01 | 0.348 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.490030e-01 | 0.348 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.586870e-01 | 0.338 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.614897e-01 | 0.336 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.616141e-01 | 0.336 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.624408e-01 | 0.335 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.668346e-01 | 0.331 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.674650e-01 | 0.330 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.800782e-01 | 0.319 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.800782e-01 | 0.319 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.800782e-01 | 0.319 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.800782e-01 | 0.319 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.800782e-01 | 0.319 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.800782e-01 | 0.319 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.800782e-01 | 0.319 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.800782e-01 | 0.319 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.800782e-01 | 0.319 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.858489e-01 | 0.313 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.858489e-01 | 0.313 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.858489e-01 | 0.313 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.858489e-01 | 0.313 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.858489e-01 | 0.313 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.858489e-01 | 0.313 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.858489e-01 | 0.313 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.858489e-01 | 0.313 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.858489e-01 | 0.313 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.858489e-01 | 0.313 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.858489e-01 | 0.313 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.858489e-01 | 0.313 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.858489e-01 | 0.313 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.967614e-01 | 0.304 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.967614e-01 | 0.304 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 4.967614e-01 | 0.304 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.967614e-01 | 0.304 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.973164e-01 | 0.303 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.973164e-01 | 0.303 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.996805e-01 | 0.301 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.053690e-01 | 0.296 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.071768e-01 | 0.295 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.071768e-01 | 0.295 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.071768e-01 | 0.295 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.100509e-01 | 0.292 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.100509e-01 | 0.292 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.100509e-01 | 0.292 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.100509e-01 | 0.292 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.100509e-01 | 0.292 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.100509e-01 | 0.292 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.149391e-01 | 0.288 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.178074e-01 | 0.286 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.200089e-01 | 0.284 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.200089e-01 | 0.284 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.200089e-01 | 0.284 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.200089e-01 | 0.284 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.268281e-01 | 0.278 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.324718e-01 | 0.274 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.324718e-01 | 0.274 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.324718e-01 | 0.274 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.324718e-01 | 0.274 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.324718e-01 | 0.274 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.324718e-01 | 0.274 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.324718e-01 | 0.274 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.324718e-01 | 0.274 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.324718e-01 | 0.274 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.324718e-01 | 0.274 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.324718e-01 | 0.274 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.324718e-01 | 0.274 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.324718e-01 | 0.274 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.324718e-01 | 0.274 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.324718e-01 | 0.274 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.324718e-01 | 0.274 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.388656e-01 | 0.269 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.388656e-01 | 0.269 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.388656e-01 | 0.269 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.388656e-01 | 0.269 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.426595e-01 | 0.265 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.426595e-01 | 0.265 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.426595e-01 | 0.265 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.431214e-01 | 0.265 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.460904e-01 | 0.263 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.460904e-01 | 0.263 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.460904e-01 | 0.263 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.493096e-01 | 0.260 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.633629e-01 | 0.249 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.646776e-01 | 0.248 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.646776e-01 | 0.248 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.646776e-01 | 0.248 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.646776e-01 | 0.248 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.649369e-01 | 0.248 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.649369e-01 | 0.248 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.664858e-01 | 0.247 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.664858e-01 | 0.247 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.664858e-01 | 0.247 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.664858e-01 | 0.247 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.664858e-01 | 0.247 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.675594e-01 | 0.246 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.710910e-01 | 0.243 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.748696e-01 | 0.240 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.748696e-01 | 0.240 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.748696e-01 | 0.240 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.748696e-01 | 0.240 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 5.748696e-01 | 0.240 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.748696e-01 | 0.240 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.748696e-01 | 0.240 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.748696e-01 | 0.240 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.748696e-01 | 0.240 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 5.748696e-01 | 0.240 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 5.748696e-01 | 0.240 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.748696e-01 | 0.240 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.748696e-01 | 0.240 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.824609e-01 | 0.235 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.824609e-01 | 0.235 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.824609e-01 | 0.235 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.860347e-01 | 0.232 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.860347e-01 | 0.232 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.860347e-01 | 0.232 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.860347e-01 | 0.232 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.890801e-01 | 0.230 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.928914e-01 | 0.227 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.928914e-01 | 0.227 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.928914e-01 | 0.227 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.928914e-01 | 0.227 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.928914e-01 | 0.227 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 5.928914e-01 | 0.227 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.928914e-01 | 0.227 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.067089e-01 | 0.217 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.067089e-01 | 0.217 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.067089e-01 | 0.217 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.092375e-01 | 0.215 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.134247e-01 | 0.212 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.134247e-01 | 0.212 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.134247e-01 | 0.212 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.134247e-01 | 0.212 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.134247e-01 | 0.212 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.134247e-01 | 0.212 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.134247e-01 | 0.212 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.134247e-01 | 0.212 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.134247e-01 | 0.212 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.142536e-01 | 0.212 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.142536e-01 | 0.212 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.180753e-01 | 0.209 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.180753e-01 | 0.209 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.180753e-01 | 0.209 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.180753e-01 | 0.209 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.180753e-01 | 0.209 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.187663e-01 | 0.208 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.209428e-01 | 0.207 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.257045e-01 | 0.204 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.266840e-01 | 0.203 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.320213e-01 | 0.199 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.360561e-01 | 0.197 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.420420e-01 | 0.192 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.420420e-01 | 0.192 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.420420e-01 | 0.192 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.420420e-01 | 0.192 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.420420e-01 | 0.192 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.420420e-01 | 0.192 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.420420e-01 | 0.192 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.420420e-01 | 0.192 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.420420e-01 | 0.192 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.444228e-01 | 0.191 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.444228e-01 | 0.191 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.459491e-01 | 0.190 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.459491e-01 | 0.190 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.484854e-01 | 0.188 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.484854e-01 | 0.188 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.484854e-01 | 0.188 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.484854e-01 | 0.188 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.484854e-01 | 0.188 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.484854e-01 | 0.188 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.484854e-01 | 0.188 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.484854e-01 | 0.188 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.484854e-01 | 0.188 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.484854e-01 | 0.188 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.484854e-01 | 0.188 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.484854e-01 | 0.188 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.486781e-01 | 0.188 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.522372e-01 | 0.186 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.530176e-01 | 0.185 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.644982e-01 | 0.178 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.648051e-01 | 0.177 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.648051e-01 | 0.177 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.648051e-01 | 0.177 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.648051e-01 | 0.177 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.648051e-01 | 0.177 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.682167e-01 | 0.175 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.743531e-01 | 0.171 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.803681e-01 | 0.167 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.803681e-01 | 0.167 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.803681e-01 | 0.167 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.803681e-01 | 0.167 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.803681e-01 | 0.167 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.803681e-01 | 0.167 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.803681e-01 | 0.167 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.803681e-01 | 0.167 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.803681e-01 | 0.167 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.803681e-01 | 0.167 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.803681e-01 | 0.167 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.823293e-01 | 0.166 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.836846e-01 | 0.165 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.860500e-01 | 0.164 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.863858e-01 | 0.163 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.863858e-01 | 0.163 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.863858e-01 | 0.163 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.863858e-01 | 0.163 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.863858e-01 | 0.163 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.008582e-01 | 0.154 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.023405e-01 | 0.153 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.068112e-01 | 0.151 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.068112e-01 | 0.151 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.068112e-01 | 0.151 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.068112e-01 | 0.151 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.068112e-01 | 0.151 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.077589e-01 | 0.150 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.093607e-01 | 0.149 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.093607e-01 | 0.149 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.093607e-01 | 0.149 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.093607e-01 | 0.149 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.093607e-01 | 0.149 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.093607e-01 | 0.149 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.093607e-01 | 0.149 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.093607e-01 | 0.149 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.093607e-01 | 0.149 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.093607e-01 | 0.149 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.093607e-01 | 0.149 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.093607e-01 | 0.149 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.093607e-01 | 0.149 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.093607e-01 | 0.149 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.113803e-01 | 0.148 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.158490e-01 | 0.145 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.158490e-01 | 0.145 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.218051e-01 | 0.142 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.261133e-01 | 0.139 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.261133e-01 | 0.139 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.261133e-01 | 0.139 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.261133e-01 | 0.139 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.261133e-01 | 0.139 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.315511e-01 | 0.136 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.357251e-01 | 0.133 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.357251e-01 | 0.133 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.357251e-01 | 0.133 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.357251e-01 | 0.133 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.357251e-01 | 0.133 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.357251e-01 | 0.133 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.357251e-01 | 0.133 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.357251e-01 | 0.133 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.357251e-01 | 0.133 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.357251e-01 | 0.133 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.357251e-01 | 0.133 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.383193e-01 | 0.132 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.443278e-01 | 0.128 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.443278e-01 | 0.128 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.465614e-01 | 0.127 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.465614e-01 | 0.127 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.465614e-01 | 0.127 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.465614e-01 | 0.127 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.501359e-01 | 0.125 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.533226e-01 | 0.123 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.596994e-01 | 0.119 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.596994e-01 | 0.119 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.596994e-01 | 0.119 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.596994e-01 | 0.119 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.596994e-01 | 0.119 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.596994e-01 | 0.119 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.596994e-01 | 0.119 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.596994e-01 | 0.119 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.596994e-01 | 0.119 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.596994e-01 | 0.119 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.596994e-01 | 0.119 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.596994e-01 | 0.119 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.614931e-01 | 0.118 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.615233e-01 | 0.118 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.615233e-01 | 0.118 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.615233e-01 | 0.118 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.644346e-01 | 0.117 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.697751e-01 | 0.114 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.745603e-01 | 0.111 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.776497e-01 | 0.109 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.776497e-01 | 0.109 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.803878e-01 | 0.108 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.815000e-01 | 0.107 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.815000e-01 | 0.107 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.815000e-01 | 0.107 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.815000e-01 | 0.107 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.815000e-01 | 0.107 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.815000e-01 | 0.107 | 0 | 0 |
| Acetylation | R-HSA-156582 | 7.815000e-01 | 0.107 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.815000e-01 | 0.107 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 7.815000e-01 | 0.107 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.815000e-01 | 0.107 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.815000e-01 | 0.107 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.815000e-01 | 0.107 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.815000e-01 | 0.107 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.815000e-01 | 0.107 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.815000e-01 | 0.107 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.815000e-01 | 0.107 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.815000e-01 | 0.107 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.821106e-01 | 0.107 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.839041e-01 | 0.106 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.850825e-01 | 0.105 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.876846e-01 | 0.104 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.928392e-01 | 0.101 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.928392e-01 | 0.101 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.928392e-01 | 0.101 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.928392e-01 | 0.101 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.928392e-01 | 0.101 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.955568e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.988191e-01 | 0.098 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.999691e-01 | 0.097 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.999691e-01 | 0.097 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.999691e-01 | 0.097 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.000294e-01 | 0.097 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.013241e-01 | 0.096 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.013241e-01 | 0.096 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.013241e-01 | 0.096 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.013241e-01 | 0.096 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.013241e-01 | 0.096 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.013241e-01 | 0.096 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.013241e-01 | 0.096 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.013241e-01 | 0.096 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.071041e-01 | 0.093 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.071041e-01 | 0.093 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.071041e-01 | 0.093 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.071041e-01 | 0.093 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.071041e-01 | 0.093 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.105192e-01 | 0.091 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.173556e-01 | 0.088 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.193506e-01 | 0.087 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.193506e-01 | 0.087 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.193506e-01 | 0.087 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.193506e-01 | 0.087 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.193506e-01 | 0.087 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.193506e-01 | 0.087 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.193506e-01 | 0.087 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.193506e-01 | 0.087 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.193506e-01 | 0.087 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.193506e-01 | 0.087 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.193506e-01 | 0.087 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.204871e-01 | 0.086 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.204871e-01 | 0.086 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.204871e-01 | 0.086 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.205548e-01 | 0.086 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.218414e-01 | 0.085 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.229316e-01 | 0.085 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.229316e-01 | 0.085 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.330307e-01 | 0.079 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.330307e-01 | 0.079 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.330307e-01 | 0.079 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.357424e-01 | 0.078 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.357424e-01 | 0.078 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.357424e-01 | 0.078 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.357424e-01 | 0.078 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.357424e-01 | 0.078 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.357424e-01 | 0.078 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.357424e-01 | 0.078 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.357424e-01 | 0.078 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.357424e-01 | 0.078 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.357424e-01 | 0.078 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.357424e-01 | 0.078 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.357424e-01 | 0.078 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.357424e-01 | 0.078 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.364234e-01 | 0.078 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.436043e-01 | 0.074 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.436043e-01 | 0.074 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.447771e-01 | 0.073 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.477586e-01 | 0.072 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.491374e-01 | 0.071 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.506478e-01 | 0.070 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.506478e-01 | 0.070 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.506478e-01 | 0.070 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.506478e-01 | 0.070 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.506478e-01 | 0.070 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.557676e-01 | 0.068 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.557676e-01 | 0.068 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.557676e-01 | 0.068 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.599574e-01 | 0.066 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.617505e-01 | 0.065 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.619443e-01 | 0.065 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.621506e-01 | 0.064 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.642014e-01 | 0.063 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.642014e-01 | 0.063 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.642014e-01 | 0.063 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.642014e-01 | 0.063 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.642014e-01 | 0.063 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.642014e-01 | 0.063 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.660425e-01 | 0.062 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.706780e-01 | 0.060 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.719024e-01 | 0.060 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.756414e-01 | 0.058 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.757585e-01 | 0.058 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.765258e-01 | 0.057 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.765258e-01 | 0.057 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.765258e-01 | 0.057 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.765258e-01 | 0.057 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.765258e-01 | 0.057 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.765258e-01 | 0.057 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.791009e-01 | 0.056 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.822135e-01 | 0.054 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.859458e-01 | 0.053 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.863436e-01 | 0.052 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.866092e-01 | 0.052 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.877323e-01 | 0.052 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.877323e-01 | 0.052 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.901159e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.929614e-01 | 0.049 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.929614e-01 | 0.049 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.929614e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.979223e-01 | 0.047 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.979223e-01 | 0.047 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 8.979223e-01 | 0.047 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 8.979223e-01 | 0.047 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.979223e-01 | 0.047 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.979223e-01 | 0.047 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 8.979223e-01 | 0.047 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.979223e-01 | 0.047 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.979223e-01 | 0.047 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.986267e-01 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.986267e-01 | 0.046 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.007546e-01 | 0.045 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.007546e-01 | 0.045 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.062085e-01 | 0.043 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.071880e-01 | 0.042 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.071880e-01 | 0.042 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.071880e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.071880e-01 | 0.042 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.071880e-01 | 0.042 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.075326e-01 | 0.042 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.080156e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.080156e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.080156e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.080156e-01 | 0.042 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.123797e-01 | 0.040 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.126756e-01 | 0.040 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.147768e-01 | 0.039 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.147768e-01 | 0.039 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.147768e-01 | 0.039 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.156131e-01 | 0.038 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.156131e-01 | 0.038 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.156131e-01 | 0.038 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.156131e-01 | 0.038 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.156131e-01 | 0.038 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.156131e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.156131e-01 | 0.038 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.203103e-01 | 0.036 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.210691e-01 | 0.036 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.210691e-01 | 0.036 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.232739e-01 | 0.035 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.232739e-01 | 0.035 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.232739e-01 | 0.035 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.250320e-01 | 0.034 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.250371e-01 | 0.034 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.269218e-01 | 0.033 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.283820e-01 | 0.032 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.283820e-01 | 0.032 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.283820e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.286965e-01 | 0.032 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.289243e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.302396e-01 | 0.031 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.302396e-01 | 0.031 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.302396e-01 | 0.031 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.302396e-01 | 0.031 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.303847e-01 | 0.031 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.323990e-01 | 0.030 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.365734e-01 | 0.028 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.365734e-01 | 0.028 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.365734e-01 | 0.028 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.365734e-01 | 0.028 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.365734e-01 | 0.028 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.374187e-01 | 0.028 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.374187e-01 | 0.028 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.374187e-01 | 0.028 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.406321e-01 | 0.027 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.415179e-01 | 0.026 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.415179e-01 | 0.026 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.421145e-01 | 0.026 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.421145e-01 | 0.026 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.423324e-01 | 0.026 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.423324e-01 | 0.026 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.423324e-01 | 0.026 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.423324e-01 | 0.026 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.423324e-01 | 0.026 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.423324e-01 | 0.026 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.457675e-01 | 0.024 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.464740e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.464740e-01 | 0.024 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.474426e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.475688e-01 | 0.023 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.475688e-01 | 0.023 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.475688e-01 | 0.023 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.475688e-01 | 0.023 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.505193e-01 | 0.022 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.505193e-01 | 0.022 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.517491e-01 | 0.021 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.517491e-01 | 0.021 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.523300e-01 | 0.021 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.523300e-01 | 0.021 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.535436e-01 | 0.021 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.560128e-01 | 0.020 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.577509e-01 | 0.019 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.590042e-01 | 0.018 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.590042e-01 | 0.018 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.601136e-01 | 0.018 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.605953e-01 | 0.017 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.641742e-01 | 0.016 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.641742e-01 | 0.016 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.641742e-01 | 0.016 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.641742e-01 | 0.016 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.644230e-01 | 0.016 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.668722e-01 | 0.015 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.668722e-01 | 0.015 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.674282e-01 | 0.014 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.674282e-01 | 0.014 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.691617e-01 | 0.014 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.703869e-01 | 0.013 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.716639e-01 | 0.012 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.718377e-01 | 0.012 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.730770e-01 | 0.012 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.730770e-01 | 0.012 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.738579e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.751646e-01 | 0.011 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.755228e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.755228e-01 | 0.011 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.770056e-01 | 0.010 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.770698e-01 | 0.010 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.777466e-01 | 0.010 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.777466e-01 | 0.010 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.777466e-01 | 0.010 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.780406e-01 | 0.010 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.794989e-01 | 0.009 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.816068e-01 | 0.008 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.822575e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.825835e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.847977e-01 | 0.007 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.847977e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.847977e-01 | 0.007 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.851467e-01 | 0.006 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.852153e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.872566e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.874354e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.884520e-01 | 0.005 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.884520e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.885774e-01 | 0.005 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.889835e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.910122e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.914177e-01 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.915342e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.925573e-01 | 0.003 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.929073e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.933809e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.933973e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.935488e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.937988e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.937988e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.945832e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.946715e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.949845e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.951560e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.959970e-01 | 0.002 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.961054e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.963611e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.963611e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.963611e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.969930e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.970060e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.974514e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.974514e-01 | 0.001 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.976378e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.977413e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.979468e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.983035e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.984579e-01 | 0.001 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.988203e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.988418e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.989472e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.989534e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.991644e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.992093e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992347e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.992783e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.993404e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.994603e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.994704e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996786e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997486e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997486e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997735e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998441e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998733e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998849e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998879e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998898e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999455e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999628e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999628e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999670e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999693e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999842e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999861e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999878e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999903e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999915e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999937e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999941e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999979e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999982e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999983e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999985e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999987e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |